Jamie Bell
Analysis shows substantial cost saving can be achieved with Philips’ DTAS...
Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the...
Vision recovery among potential benefits of endovascular therapy in PCA occlusion...
A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased...
Combined neuroprotection therapy shows promise in experimental stroke model
A new study conducted by scientists at Louisiana State University (LSU) Health New Orleans Neuroscience Center of Excellence (New Orleans, USA) reports that the...
Researchers identify novel protein linked to ischaemic stroke risk in older...
By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be...
Imperative announces data demonstrating benefits of Zoom RDL system in neurointerventional...
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial...
Precision Neuroscience begins first-in-human study of implantable BCI technology
Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed....
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
New study elucidates exact location of atherosclerotic plaque ruptures in carotid...
While the exact location of atherosclerotic plaque ruptures—a common cause of myocardial infarction (MI) and stroke—has previously been unknown, researchers at Lund University (Lund,...
NeuroNews’ top 10 most popular stories of May 2023
While a handful of our highlights from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) unsurprisingly feature in NeuroNews’ most-read stories through...
MAGNA meta-analysis further supports clinical benefit of EVT in large-core infarct...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic...
Early Feasibility Study programme has potential to advance US neurovascular space
At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation...
Anuncia announces publication of “promising” hydrocephalus outcomes with ReFlow ventricular system
Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus...
Nalu Medical announces first enrolment in peripheral nerve stimulation RCT
Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS)...
Combined thrombectomy technique fails to demonstrate superiority over aspiration alone
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...
NeuroNews issue 50 – US
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...
NeuroNews issue 50 – EU
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...
TESLA trial misses primary endpoint but exhibits “strong suggestion” favouring endovascular...
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion”...
Penumbra expands computer-aided thrombectomy offering with Lightning Bolt 7 launch
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Bolt 7, which the company claims is the most...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
First surgical cases underway using Stryker’s Q guidance system with cranial...
Stryker has announced that Early Product Surveillance (EPS) cases utilising its Q guidance system with cranial guidance software are underway. The technology provides surgeons with...
IRIS data shed new light on how treatment delays may impact...
A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT...
Nicolab awarded three-year contract to supply AI-powered stroke software in Australia
Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine...
EOSolutions announces full commercial launch of Dr Banner balloon guide catheter
EOSolutions Corporation has announced the introduction of the Dr Banner balloon guide catheter (BGC), which boasts “unmatched features” for neurovascular procedures. As per a...
Performance feedback significantly reduces door-to-groin time in endovascular therapy
Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving...
Brain-computer interface plus SCS therapy enables thought-controlled walking after spinal cord...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy....
“Sonolysis is back” after safely reducing endarterectomy stroke risk in randomised...
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
NeuroOne announces first clinical case using Evo sEEG electrode in robotic...
NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery.
Performed by William Bingaman at Cleveland Clinic in Cleveland,...
Pipeline Flex embolisation device deemed safe and effective in complex intracranial...
A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial...
Artiria granted US FDA clearance for real-time, deflectable guidewire
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug...
Interim data find “no evidence of benefit” for carotid revascularisation additional...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
New data represent “fantastic news” in IVT despite lack of efficacy...
Results from the TIMELESS trial represent “fantastic news” on the safety of intravenous tenecteplase in selected late-window stroke patients, despite the drug failing to...
Structured ambulatory post-stroke care “requires further evaluation” following mixed trial results
While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors...
STRIVE-2 neuroimaging standards provide “unique focus” on small vessel disease research
In an attempt to promote more consistent and higher quality research in the field of small vessel disease (SVD), international experts have published the...
Remote ischaemic conditioning fails to improve functional outcomes in acute stroke...
As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes...
Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke...
AI tool outperforms human emergency call handlers in identifying stroke
A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by...
WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
Open and endovascular surgery recommended over ligation in ruptured extracranial carotid...
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms....
ChatGPT outperforms medical students and matches residents on neurosurgical board-style questions
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the...
Abbott gains US FDA nod to treat non-surgical back pain with...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic...
AHA: Systemic interventions key to tackling “enormous inequities” in stroke care
‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not...
RapidAI wins MedTech Breakthrough award for best new imaging solution
RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the...
Magnus shares study results indicating SAINT depression treatment changes abnormal brain...
Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation...
Office-based removal of sacral neuromodulation devices deemed safe and well-tolerated
As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a...
Carthera publishes “promising” results with SonoCloud-9 in glioblastoma patients
Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University...
MR CLEAN-LATE trial finds endovascular therapy safe and effective in late-presenting...
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present...
Abbott announces expanded MRI labelling for Eterna spinal cord stimulation system
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its Eterna spinal cord...
European Academy of Neurology launches collaboration to address global brain disorder...
Earlier this week, the European Academy of Neurology (EAN) announced the launch of the Brain Health Mission, a collaborative initiative that aims to address...
‘We need better tools’—new intracranial stent devices required for rare stroke...
“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a...
Hubly Surgical gains US FDA clearance for novel burr-hole placement device
Hubly Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Hubly Drill, which the company describes as an innovative...
Get Ahead of Stroke campaign launches Survive Stroke Week from 15–21...
The Get Ahead of Stroke campaign is launching Survive Stroke Week from 15–21 May—an observance aimed at increasing awareness of stroke symptoms and the...
World-renowned clot science drives outstanding EMBOTRAP stent retriever outcomes in MASTRO...
This advertorial is sponsored by CERENOVUS.
The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design...
Cerevasc to present data on minimally invasive CNS delivery system at...
Cerevasc has announced that data on its minimally invasive central nervous system (CNS) delivery system will be presented for the first time at the...
Computing the future: Exploring ChatGPT’s potential role in neurosurgical practice
Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not...
Systematic review queries how far PPTA aneurysm management is along “the...
A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery...
ConcertAI’s TeraRecon announces release of AI-driven Neuro Suite
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage,...
MIVI completes enrolment for study of Q revascularisation system in acute...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...
Medical therapy improvements mean “the time has come” to reconduct prior...
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward...
Clinical stroke research in Canada receives million-dollar grant boost
The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this...
NeuroNews’ top 10 most popular stories of April 2023
A number of potentially contentious issues caught the eye of our readers in April—including how best to define 'success' in stroke thrombectomy; efforts to...
NeuroOne announces US commercial launch of Evo sEEG electrodes
NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA.
Zimmer Biomet holds exclusive worldwide distribution rights...
Feinstein Institutes awarded US$3.4 million to study rTMS therapy in schizophrenia
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening...
Stryker completes acquisition of Cerus Endovascular
Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices...
Study finds worse post-stroke neurologic outcomes in Spanish-speaking Americans
New research has indicated that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans.
A recent study, which looked at whether the...
Cerenovus announces commercial availability of Cerepak detachable coils in USA
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been...
Early diagnosis and treatment needed in “often underreported” post-stroke cognitive impairment
More than half of all stroke survivors may develop cognitive impairment within a year after their stroke, and one in three are at risk for developing dementia...
ESOC to return with fully on-site format and diverse stroke programme
Having taken place via a virtual format in 2021, and as a hybrid meeting last year, the 2023 European Stroke Organisation Conference (ESOC; 24–26...
SynerFuse announces presentation of IDE proof-of-concept study data
SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s...
Vascular community split over “death” of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on...
Penumbra launches new RED 43 reperfusion catheter for mechanical thrombectomy
Penumbra recently announced the launch of the latest addition to its RED family of catheter devices for mechanical thrombectomy, the RED 43 reperfusion catheter.
According...
NICO announces initial positive results from ENRICH trial
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting...
Route 92 gains US FDA clearance for complete stroke treatment system
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system,...
Biotronik announces US FDA approval of Prospera spinal cord stimulation system
Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the...
Cercare and ConcertAI partner to improve neurovascular clinical workflows
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of...
ENRICH trial data on minimally invasive ICH surgery to be presented...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...
RapidAI receives US FDA 510(k) clearance for new imaging product to...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is...
New WIST guidelines seek to improve access and standardise training in...
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in...
Nerivio demonstrates real-world effectiveness as migraine treatment in adolescents
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology....
Michael J Fox Foundation announces “significant breakthrough” in search for Parkinson’s...
A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF)...
The new standard for SCS therapy—neural activation measurement, targeting and maintenance
Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In...
Initial cases indicate lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Adept launches Adducted Arm Scoop product for use during image-guided procedures
Adept Medical has launched the Adducted Arm Scoop—an improved solution for supporting the adducted arms of supine patients during image-guided procedures.
Adept’s new, “extremely durable”...
Saluda, Neuromod, Neuvotion secure funding rounds to boost neuromodulation technologies
This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of...
Evidence indicates effectiveness of brain stimulation in upper-limb stroke rehabilitation
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and...
Annalise.ai gains seven new 510(k) clearances for brain and chest imaging...
Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence...
DAPT at discharge reduces stroke and mortality risk versus other drug...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT),...
Reach Neuro receives Breakthrough Device designation for restorative stimulation device in...
Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small...
Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...
New study shows benefits of BioWave’s peripheral nerve stimulation in chronic...
The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral...
First-pass effect or rule of three? Definition of procedural success remains...
While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical...
Intraoperative adverse events found to impede favourable outcomes in microsurgical aneurysm...
A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated with microsurgery experienced favourable...
New spectroscopy probe could enhance deep brain stimulation procedures for Parkinson’s
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors...
Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...
Astrocyte to initiate extended infusion Phase 1b study of cerebroprotective drug
Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers....
CHI Memorial announces participation in “milestone” stroke study with novel ultrasound...
The Catholic Health Initiatives (CHI) Memorial Stroke and Neuroscience Center has announced its participation in the national research study, BUBL, stating that it was...
Stent-assisted coiling fails to show superiority versus coiling alone in unruptured...
A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured...
NeuroNews’ top 10 most popular stories of March 2023
In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s...
Review concludes SCS benefits do not outweigh associated risks and costs...
A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated...
NeuroNews issue 49 – US
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...
NeuroNews issue 49 – EU
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...
Trial underway involving neurointerventionist “retaliated against” for refusing concurrent on-call shifts
The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his...
Chest, Heart and Stroke Scotland applauds decision to reinstate “vital” thrombectomy...
The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Q’Apel Medical granted CE-mark approval for Walrus balloon guide catheter
Q'Apel Medical has been granted a CE mark under the European Medical Device Regulation (MDR) for Walrus, its balloon guide catheter (BGC) product used...
Vitor Mendes Pereira
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something...
Cerevasc appoints Adel Malek as its new chief medical officer
Cerevasc has named neurosurgeon Adel Malek as its new chief medical officer. This appointment will allow the company to further accelerate the development and clinical...
Brain Aneurysm Foundation welcomes Carolina Maier to its board of directors
The Brain Aneurysm Foundation (BAF), a leading global research and advocacy organisation committed to improving treatment and care for brain aneurysms, has announced the addition...
Lessons learned from establishing a 24/7 stroke thrombectomy service
Alongside his colleagues at the Barts Health NHS Trust, Levansri Makalanda (London, UK) was responsible for setting up the second ever 24/7 mechanical thrombectomy...
Recent addition to European flow diverter market performs well in multicentre...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...
Athersys announces changes to MASTERS-2 trial endpoints following US FDA meeting
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the US Food and Drug Administration (FDA)....
Brainomix receives US FDA clearance for flagship stroke AI imaging software
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to...
COMMAND trial set to begin enrolment at third US site
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health...
Female physicians in neurointerventional surgery: Breaking down barriers
In the latter stages of 2022, the Society of NeuroInterventional Surgery (SNIS) released a position statement advocating pregnancy and parental leave policies in neurointerventional...
UK MHRA awarded £10 million to fast-track patient access to medical...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of...
ObvioHealth to conduct decentralised trial with Mi-Helper device for treatment of...
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the treatment of migraines. The...
NeuroOne completes initial animal implant of thin-film paddle lead for spinal...
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS)....
MindRhythm announces publication of EPISODE-PS trial data on ischaemic stroke detection...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), has announced the first publication of results from its EPISODE-PS trial in...
Dystonia patient undergoes successful brain pacemaker surgery while watching cartoons
A dystonia patient in Turkey who had been having uncontrollable involuntary contractions in her legs and arms for the past five years recently underwent...
Scientia receives US FDA clearance for Aristotle Colossus macrowire
Scientia Vascular has announced the US Food and Drug Administration (FDA) 510(k) clearance of the Aristotle Colossus macrowire. The company claims that this device...
Carthera and US FDA align on key aspects of potential pivotal...
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of brain diseases—has announced today the completion of an end-of-Phase...
European Society for Brain Stimulation “strongly opposes” reclassification of non-invasive devices
The European Society for Brain Stimulation (ESBS) has said it “strongly opposes” the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation (NIBS)...
Get Ahead of Stroke campaign debuts new online resources for EMS...
With Brain Awareness Week (13–19 March) approaching, the Get Ahead of Stroke campaign has announced it is debuting new online resources for emergency medical...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Study finds “dismally low” global access to thrombectomy and “enormous disparity”...
The Society of Vascular and Interventional Neurology (SVIN) has released its first global analysis of access to mechanical thrombectomy for the treatment of large...
Neuromod gains US FDA approval for bimodal neuromodulation tinnitus treatment
Neuromod Devices has announced that the US Food and Drug Administration (FDA) has granted de novo approval to Lenire—the first bimodal neuromodulation device of its kind...
Nevro announces full US market launch of HFX iQ spinal cord...
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following...
Five-year project sets out to improve brain aneurysm treatments with customisable...
A team from the University of Oklahoma (Norman, USA) has embarked on a five-year research project with the intention of designing a device that...
Minneapolis hospital opens “nation’s first” paediatric hybrid intraoperative MRI neurosurgery suite
Children's Minnesota (Minneapolis, USA) has claimed, in a press release, to have become the first health system in North America to open a paediatric hybrid intraoperative magnetic resonance...
Mainstay announces publication detailing economic impact of restorative neurostimulation
Mainstay Medical has announced the publication of a paper, titled “Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact",...
Spinal cord stimulation found to “instantly improve” post-stroke arm and hand...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to...
US physicians publish “first reported use” of Indigo aspiration system for...
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus...
Increasing coiling porosity demonstrates greater impact in male cerebral aneurysm patients
Altering the porosity of coiling in the treatment of cerebral aneurysms has been found to have a greater impact on maximum oscillatory shear index...
NeuroNews’ top 10 most popular stories of February 2023
Stroke research was the flavour of the month throughout February on NeuroNews, with highlights from the International Stroke Conference (ISC; 8–10 February, Dallas, USA)...
Drug-free migraine treatment gains additional US FDA clearance for preventative use
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive...
NovaSignal announces donation of NovaGuide 2 intelligent ultrasound system to Jacobs...
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke...
Feinstein Institutes reports on early vagus nerve mapping and details novel...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve...
Route 92 announces 80th patent for Monopoint operating platform
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is...
High-frequency spinal cord stimulation may be associated with “significant decrease” in...
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs,...
Methinks receives CE-mark certification for AI-based stroke triage software
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of...
Hotter weather during transportation associated with improved thrombectomy outcomes
A study intended to examine the impact of different weather conditions and modes of transport on mechanical thrombectomies in stroke patients has found a...
Uric acid-based neuroprotective agent demonstrates promise in large animal study
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that...
Cognito announces first patient enrolment in US pivotal study of novel...
Cognito Therapeutics has announced the first patient enrolment in its US pivotal study, HOPE, which is designed to demonstrate the safety and efficacy of...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Incepto partners with Avicenna.AI to improve stroke management in Europe
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform...
Randomised trial fails to show benefit with bypass surgery in symptomatic...
The initial findings from a recent randomised controlled trial (RCT) do not support the addition of extracranial to intracranial (EC-IC) bypass surgery to the...
ANGEL-ASPECT data bolster evidence for thrombectomy in large infarct core stroke
A randomised trial has found mechanical thrombectomy procedures performed within 24 hours of symptom onset to be more effective than standard medical care in...
Brainomix technology integrated into new UK atrial fibrillation study
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
Trend toward gender parity in faculty “has not translated” to stroke...
The favourable trend toward gender parity that has been seen within neurology faculty over the past decade “has not translated” to the leadership of...
Viz.ai collaborates with Johns Hopkins to expedite patient enrolment in brain...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for...
Thrombectomy appears comparable to medical management in treating ACA occlusion stroke
Mechanical thrombectomy appears to be a safe and technically feasible treatment option for ischaemic strokes caused by primary isolated anterior cerebral artery (ACA) occlusions...
Dual antiplatelet therapy comparable to thrombolysis in minor, non-disabling ischaemic stroke
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to...
The positive clinical impact of a comprehensive, compatible stroke solutions portfolio
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices,...
Randomised trial finds active tDCS to be effective treatment in women...
A randomised, triple-blinded clinical trial involving 35 women has found that active transcranial direct current stimulation (tDCS)—delivered at an intensity of 2mA and across...
Rhaeos raises US$10.5 million in Series A funding to boost hydrocephalus...
Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more...
Athersys granted clinical Type B meeting with US FDA to discuss...
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with...
New certifications aim to standardise and improve stroke care in Mexico
Hospital institutions in Mexico will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Mexican stroke...
Perfuze announces US FDA clearance and first US clinical use of...
Perfuze has secured its first product clearance from the US Food and Drug Administration (FDA) for the company’s Millipede 088 access catheter. The first...
MindMaze launches Izar neurological rehabilitation device in USA and Europe
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked...
Celery seed derivative shows promise as neuroprotectant in acute ischaemic stroke
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological...
IRRAflow system leads to favourable clinical outcomes versus passive drainage in...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the...
Chinese TRACE II trial deems tenecteplase non-inferior to alteplase in ischaemic...
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used...
New smartphone app may help to identify stroke symptoms as they...
A new smartphone application called FAST.AI (Neuronics Medical) may help people who are having a stroke—or their family and caregivers—to recognise common stroke symptoms in real...
Wallaby/Phenox announces presentation of PROST trial data at ISC 2023
Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of the PROST (Preset for occlusive stroke treatment) randomised clinical...
EndoStream announces first patient enrolment in TORNADO-US study
EndoStream Medical has announced that the first patient has been enrolled in the TORNADO-US clinical study in the USA, which will evaluate the Nautilus intrasaccular system...
SELECT2 results support thrombectomy use in stroke patients with large infarct-core...
An international clinical study has found that patients experiencing a ‘large’ stroke—characterised by a greater infarct-core volume on imaging—had a dramatically better recovery after...
ISC 2023 sees presentation of positive data on new stroke drugs...
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke...
Blood pressure lowering after EVT “should be customised” owing to safety...
The administration of medications to lower systolic blood pressure in acute ischaemic stroke patients who have undergone a successful mechanical thrombectomy procedure—also known as...
Hyperfine announces new data on portable MRI in post-thrombectomy stroke patients
Hyperfine has announced the presentation of new stroke patient follow-up data regarding the use of the Swoop system—which it claims is the world’s first US...
Two cardiovascular medicines found to be “well-tolerated” in small vessel stroke
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for...
Wallaby/Phenox announces US FDA clearance of Preset thrombectomy device
Phenox, a Wallaby Medical company, has announced the US Food and Drug Administration (FDA) 510(k) clearance of its Preset thrombectomy device for the treatment...
Continuous monitoring detects atrial fibrillation in 20% of atherosclerotic stroke survivors
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...
Real-world study demonstrates “highly clinically important” time saving with Viz platform
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which...
Neuroprotective agent linked to reduced death and disability in ischaemic stroke...
ApTOLL, a neuroprotectant medication intended to shield the brain from tissue damage, has been linked to reduced death and disability when used alongside standard...
Avicenna.AI announces total funding of US$10 million after securing Series A...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round...
Imperative Care announces formation of digital stroke recovery company Kandu Health
Imperative Care has announced the formation of digital health startup Kandu Health as an independent company, with the aim of “changing the course of stroke...
Prior thrombolysis improves outcomes for M2 occlusion stroke patients undergoing thrombectomy
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes than thrombectomy alone in stroke patients with M2 occlusions,...
New AHA statement should be seen as “call to action” in...
A new American Heart Association (AHA) scientific statement provides guidance on staffing, leadership and resource requirements for hospital stroke centres, with the intention of...
Czech study finds thrombectomy and IVT rates “remained unchanged” during first...
A national study conducted by researchers in the Czech Republic has found that, while stroke admissions in the country declined during the first year...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
New JMIR journal to focus on “intersection between clinical neuroscience and...
JMIR Publications has announced the expansion of its journal portfolio with JMIR Neurotechnology (JNT)—an open-access, peer-reviewed journal focused on the intersection between clinical neuroscience and...
SCS therapies can play a role in cancer-related pain treatment despite...
Spinal cord stimulation (SCS) therapies targeting the dorsal column “may be considered” within the multimodal treatment plans typically required by cancer patients, but it...
LivaNova launches new vagus nerve stimulation therapy for drug-resistant epilepsy
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with...
Meta-analysis including recent basilar trials signals benefit of EVT in posterior...
A meta-analysis of recent basilar artery occlusion trials—including ATTENTION and BAOCHE—has further indicated the potential benefits held by endovascular therapy (EVT) in treating posterior-circulation...
NeuroNews’ top 10 most popular stories of January 2023
The latest and greatest in neurointerventional technologies feature among NeuroNews’ most read stories from January, including a direct intravascular imaging tool; a new, stroke-specific...
Basking Biosciences to present trial data on novel reversible thrombolytic agent...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic...
Axonics receives US FDA approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation (SNM) system—a technology intended to provide...
Sex found to be “important variable” in study and treatment of...
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Global societies lead tributes to esteemed neurologist Ralph Sacco
Esteemed neurologist Ralph Sacco passed away at the age of 65 earlier this month, and a number of prominent neurology and stroke societies have...
Boston Scientific announces three-month data from SOLIS trial at NANS
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes to conventional medical management (CMM) in chronic pain patients...
Thrombectomy use rates underscore recent advances in Latin American stroke care
A systematic review of interventional acute ischaemic stroke treatments in Latin American countries has found that mechanical thrombectomy usage in these regions is “comparable...
Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from...
Abbott gains US FDA approval for SCS therapy in painful diabetic...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful...
Transcutaneous auricular VNS proves effective in patients with mild cognitive impairment
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive...
CELLO II balloon guide catheter gains US FDA approval for peripheral...
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can...
Blackford and Brainomix announce partnership to advance AI-assisted stroke care
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...
Chinese MATCH study finds microsurgery is “dominant” brain AVM treatment
Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland China and produced early findings indicating that microsurgery is...
Hospitals without high-level designation more likely to miss strokes following TAVI...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that...
ENCHANTED2/MT data indicate intensive blood pressure lowering “should be avoided” after...
Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure...
Clinical trial to test novel wearable treatment for chronic pain and...
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will...
Novel digital intervention meets primary endpoint in chronic stroke trial
MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was...
Basecamp Vascular announces upcoming appointment of new CEO
Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023.
He succeeds interventional neuroradiologist Raphaël Blanc (Foundation Rothschild...
Challenging the status quo in stroke care
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...
AHA statement: Even transient stroke symptoms require emergency assessment
Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke,...
Squid liquid embolic agent deemed safe and effective for high-grade DAVFs
The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the...
Saluda Medical announces presentation of 36-month EVOKE trial data at NANS...
Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual...
Atrial fibrillation does not modify treatment effect of bridging thrombolysis, study...
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...
Abbott presents new data on streamlining patient-reported measures, BurstDR and more...
Abbott presented new data in more than 30 presentations and posters at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las...
Interventions—not neuroimaging—found to be driving increased ischaemic stroke costs
A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from...
Neuralace enrols first patients in AT-PDN study evaluating Axon therapy
Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study.
The multicentre AT-PDN study...
Neuroprotection “renaissance” offers hope for improved stroke therapies in future
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears...
First human cases performed with high-frequency imaging offering “unprecedented potential” in...
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company...
Systematic review deems coated stents plus SAPT feasible in ruptured aneurysms
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to...
Athersys provides update on ischaemic stroke and haemorrhagic trauma trials of...
Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided...
Medtronic to highlight sensing-enabled spinal cord stimulation research at NANS 2023
Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal cord stimulation (SCS) therapy at the North American Neuromodulation...
So, you want to be a principal investigator?
A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and...
Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...
DISTAL trial will elucidate non-dominant M2, M3 and PCA occlusions but...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December...
SynerFuse announces “milestone” solo spine surgeon procedure in DRG stimulation study
Justin Zenanko, the CEO of SynerFuse, announced today that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse...
Nalu Medical announces publication of two spinal cord stimulation clinical studies
Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve...
NeuroNews’ top 10 most popular stories of December 2022
The final weeks of 2022 saw the global burden of stroke gain a great deal of attention from NeuroNews’ online audience, including discussions around...
Mathematical model examines factors influencing risk of cerebral aneurysm rupture
Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including shape and size—that influence aneurysm rupture risks prior to...
Nevro announces two late-breaking data presentations set for NANS 2023
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been...
Increased annual stroke rate in Canada underscores need for strong treatments...
A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This...
Imperative Care announces FDA clearance and initial cases with stroke-specific radial...
Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s...
Abbott launches “world’s smallest” implantable, rechargeable SCS system for chronic pain
Abbott has announced the US Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which it claims is...
Insightec receives US FDA approval to treat essential tremor patients’ second...
Insightec recently announced it has received an additional US Food and Drug Administration (FDA) approval for treatment of essential tremor using its Exablate Neuro...
Study reveals racial disparity in brain tumour surgeries recommended to US...
A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published...
Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...
European Stroke Organisation taskforce delivers update on thrombolytic drug shortages
The thrombolysis taskforce of the European Stroke Organisation (ESO) executive committee has provided an update on current shortages of alteplase and tenecteplase, detailing outcomes...
Shelley Renowden
Through her many years as a consultant neuroradiologist at the North Bristol NHS Trust (Bristol, UK), as well as organising the European Course in...
Study indicates safety of novel transmural access to carotid artery perivascular...
A transmural approach for accessing the perivascular tissues of the cervical carotid artery has been deemed safe following initial evaluations in a swine model.
Geoffrey...
Technological advances could render 3D printing a “major manufacturing tool” for...
The utilisation of 3D printing to make drug-eluting stents may currently be in its infancy, but the advantages it carries—such as the ability to...
Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...
Sonorous uses new device to treat patients with symptomatic cerebral venous...
Sonorous NV has announced the treatment of the first patients in North America with the BossStent device, which is designed to treat patients with...
Stryker launches “state-of-the-art” neurovascular lab to accelerate stroke care innovation
Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology...
How do we improve the treatment of stroke patients in the...
This educational supplement has been sponsored by MicroVention.
Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several...
Current literature supports stenting as feasible bailout option after failed thrombectomy
Permanent intracranial stenting offers a feasible, safe ‘bailout’ option following a failed mechanical thrombectomy procedure. This was the concluding message delivered recently by Sarah...
NeuroNews issue 48 – US
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...
NeuroNews issue 48 – EU
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...
Medtronic Neurovascular partners with Avail to boost real-time connectivity
Medtronic Neurovascular has announced a new partnership with Avail Medsystems, creating the Medtronic Remote Connectivity Program (Medtronic RCP) in the process.
The goal of this...
Spinal cord stimulation and other modalities will benefit from greater understanding...
Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned...
Axonics gains Health Canada approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system as a treatment for bladder and bowel dysfunction.
The newly...
IRRAS receives new US FDA 510(k) clearance for next-generation IRRAflow control...
IRRAS has announced that it recently received regulatory clearance from the US Food and Drug Administration (FDA) to activate all of the functionality on...
Eight winners advance to Phase 2 in Neuromod Prize competition
Eight winners have been exclusively invited to join Phase 2 of the Neuromod Prize, a US$9.8 million competition to accelerate the development of targeted...
NeuroOne successfully completes feasibility study with OneRF ablation system
NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted...
NeuroNews’ top 10 most popular stories of November 2022
Key announcements from a number of the neurovascular market's leading companies generated interest from NeuroNews' online readers last month, including updates from the recent...
Timothy Deer to receive inaugural NANS Presidential Merit Award
Renowned pain management expert and clinical professor of anaesthesiology Timothy Deer (West Virginia University, Charleston, USA) is set to receive the inaugural Presidential Merit...
Study identifies “urgent need” to reduce burden of ischaemic stroke in...
A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions,...
Intraoperative neuromonitoring may drive a new era in spinal cord stimulation...
“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the...
Clinicians urge Scottish government to reverse £7 million thrombectomy funding cut
Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding...
Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Wise receives US FDA clearance for intraoperative monitoring cortical strip
Wise, a company that develops next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing applications, has announced the US Food and Drug Administration (FDA)...
LuSeed Vascular appoints Robert Stern to board of directors
LuSeed Vascular has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as the vice chairman of the company’s...
SNIS: Physicians “should not have to choose” between family life and...
The Society of NeuroInterventional Surgery (SNIS) has released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, also voicing support for...
NeuroPace initiates feasibility study of responsive neurostimulation for Lennox-Gastaut syndrome
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was...
Viz.ai partners with Cercare to support neurovascular clinical decision-making
Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...
Neurologica announces US FDA 510(k) clearance of BodyTom 64
Neurologica, a subsidiary of Samsung Electronics, has announced that its head-to-toe trauma imaging solution—the BodyTom 64 point-of-care mobile computed tomography (CT) scanner—has received 510(k) clearance...
Cerevasc co-founders honoured with Innovation Award at SVIN 2022
Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and...
Swiss parliament votes to accept US FDA-approved medical devices
The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland.
A motion...
RSNA 2022: New research improves understanding of ADHD, migraine and post-COVID...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new...
Vesalio appoints VP of US sales, announces publication of “impressive” first-pass...
Vesalio has today announced the appointment of a new vice president (VP) of US sales, Bob Bushok, who will oversee commercial strategy and execution...
Abbott to receive multiple CES 2023 awards for neurostimulation and pacemaker...
Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards...
Aidoc secures new FDA clearances for neurovascular and cardiovascular detection tools
Aidoc has announced it has increased its total number of US Food and Drug Administration (FDA) clearances to 11 with the addition of two...
Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment
Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...
Intermittent stimulation of the DRG produces comparable chronic pain results to...
Intermittent dorsal root ganglion stimulation (DRG-S) has been shown to produce comparable results to continuous stimulation across a two-week period, as reported in Neuromodulation:...
Mainstay announces publication of post-market data from ongoing chronic low back...
Mainstay Medical has announced the publication of data from a single-centre, real-world study with one-year clinical follow-up of patients selected from its ReActiv8-C study,...
Avicenna.AI partners with CARPL.ai to provide AI-powered radiology solutions
Avicenna.AI has today announced a distribution agreement with CARPL.ai—a company providing a technology platform that enables service-provider-oriented testing, validation and deployment of artificial intelligence...
NoNO announces first patient dosed with NoNO-42 in Phase 1 study
NoNO Inc has announced the dosing of the first participant in its Phase 1 clinical trial evaluating NoNO-42—a next-generation neuroprotective drug developed in the...
Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...
The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...
Why responsive neurostimulation is garnering “wide interest” from the epilepsy field
To date, thalamic responsive neurostimulation (RNS) has shown real potential in the treatment of patients with drug-resistant epilepsy. Mark Richardson (Massachusetts General Hospital, Boston,...
Cerenovus reveals positive stent-retriever thrombectomy outcomes within EXCELLENT registry
Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...
SPR Therapeutics debuts occipital nerve stimulation data at ASRA 2022
At the 21st annual American Society of Regional Anesthesia (ASRA) pain medicine meeting (17–19 November 2022, Orlando, USA), SPR Therapeutics is highlighting five new data sets demonstrating...
Route 92 Medical announces expansion to new manufacturing site in Utah
Route 92 Medical has announced its expansion to a new high-volume manufacturing site in Salt Lake City, USA. This 40,000-square-foot site will allow Route...
IRRAS announces commercial US partnership with Medtronic for IRRAflow system
IRRAS recently announced it has signed a sales agency agreement to promote its IRRAflow system in the USA with Medtronic.
During the initial pilot phase of this...
World Stroke Congress bolsters evidence on optimal thrombectomy and thrombolysis approaches
While much-needed improvements to existing triage and transport protocols for acute stroke patients were a leading topic of focus on World Stroke Day (29...
Collavidence: A global project looking to break down longstanding barriers in...
As per its own mission statement, Collavidence wants to “make medical research collaboration and funding easier, more accessible and more transparent”, paying mind to...
Contego completes enrolment of PERFORMANCE II carotid stent trial
Contego Medical has announced that enrolment of the PERFORMANCE II clinical trial has been completed.
PERFORMANCE II is intended to evaluate the safety and effectiveness...
CVRx launches new version of neuromodulation device intended to treat heart...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...
Brainomix and Visionable announce partnership to optimise UK stroke care pathway
Brainomix is set to strategically partner with Visionable, a real-time clinical collaboration platform designed to enable virtual healthcare models, in an attempt to transform...
New study finds 85% of aneurysms identified by Viz ANEURYSM had...
Viz.ai has shared highlights from new data set to be presented at next week’s Society of Vascular and Interventional Neuroradiology (SVIN) annual meeting (16–19...
Optically generated focused ultrasound shows promise for non-invasive brain stimulation
In a new paper published in Light: Science and Applications, a team of scientists and engineers led by Ji-Xin Cheng and Chen Yang (Boston...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
Positive animal-model results with ABILITY BCI are “important step” towards human...
The Wyss Center for Bio and Neuroengineering in Geneva, Switzerland has today revealed the latest preclinical neural data acquired with its fully implantable ABILITY...
Insightec announces sustained and significant tremor improvement with focused ultrasound thalamotomy
Insightec has announced the publication of what it claims is the largest prospective, long-term follow-up study to date of unilateral magnetic resonance imaging-guided focused...
NeuroNews’ top 10 most popular stories of October 2022
A common theme surrounding last month's World Stroke Day (29 October) was the fact that, while acute ischaemic stroke therapies may have advanced markedly...
New CMS telehealth designation extends coverage of Abbott’s NeuroSphere virtual clinic
As part of its Medicare Telehealth Services List, the US Centers for Medicare and Medicaid Services (CMS) will continue to cover the use of...
iVascular launches new neurovascular portfolio with four CE-marked devices
Vascular device company iVascular has announced the expansion of its therapeutic areas with the launch of a new neurovascular pipeline, having gained CE-mark approval...
BAOCHE trial results supporting thrombectomy for basilar artery stroke published in...
Results from the BAOCHE randomised controlled trial (RCT), which found that the addition of thrombectomy to standard medical care within 6–24 hours in basilar...
Medtronic study finds post-stroke protocols “vary significantly” between community hospitals and...
Medtronic has announced the first results from its DiVERT clinical study, which showed that post-stroke workflow protocols and cardiac monitoring vary significantly across community...
World Stroke Day: WSO to launch new Stroke Certification initiative
On World Stroke Day (29 October 2022), the World Stroke Organization (WSO) has announced the launch of a new programme that aims to drive...
BE FAST: Physicians advocate greater public awareness on World Stroke Day
On World Stroke Day 2022 (29 October), US physicians from the Get Ahead of Stroke campaign are urging the public to embrace the “simple...
Synchron to begin COMMAND trial enrolment at University of Pittsburgh
Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA.
The COMMAND trial is an early...
Medtronic announces launch of neurovascular Co-Lab platform
Medtronic has announced the launch of its neurovascular Co-Lab platform, which is designed to accelerate "urgently needed" innovation in stroke care and treatment.
The company...
NICO raises US$12.5 million in oversubscribed investment round
NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...
NeuroOne receives US FDA 510(k) clearance to market Evo sEEG system...
NeuroOne Medical Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology...
Bruce Ovbiagele named editor-in-chief of the Journal of the American Heart...
Bruce Ovbiagele, associate dean and professor of neurology at the University of California San Francisco (UCSF; San Francisco, USA) and chief of staff at...
Philips to highlight latest advances in stroke care at 2022 World...
Royal Philips today announced it will showcase the company’s latest advances to support the treatment of stroke patients at the 14th annual World Stroke...
Vessel-wall imaging could hold the key in “known yet understudied” phenomenon...
Following the publication of a case report in Topics in Magnetic Resonance Imaging, researchers from Malaysia have indicated that the use of vessel-wall imaging...
Axoft launches ‘soft’ brain-implant technology, gains US FDA Breakthrough Device designation
Neurotechnology start-up Axoft has launched and announced US Food and Drug Administration (FDA) Breakthrough Device designation for its brain-machine interface (BMI) technology intended to...
Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments
Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...
Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial
Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...
RAPID Aneurysm programme shows positive early performance in retrospective study
RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
Vesalio announces EU MDR certification of neurovascular product lines
Vesalio has announced EU Medical Device Regulation (MDR) certification of its product lines—achieving this “significantly ahead” of its May 2023 deadline, according to a...
Systematic review finds “strong evidence base” supporting deep brain stimulation for...
Deep brain stimulation (DBS) can halve the symptoms of severe obsessive-compulsive disorder (OCD), according to the findings of a pooled data analysis of available...
New white paper details early experience with ABILITY brain-computer interface
A new white paper, released by the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), reveals the first neural signals recorded by the ABILITY...
Nevro announces US FDA approval of HFX iQ system to personalise...
Nevro Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS)...
Society of Vascular and Interventional Neurology announces 40-second stroke awareness challenge
The Society of Vascular and Interventional Neurology (SVIN) has said it wants to create awareness around stroke events leading up to World Stroke Day...
NeuroPace announces first patient implant in NAUTILUS pivotal study
NeuroPace has announced the first patient has been implanted in the NAUTILUS clinical trial, a pivotal study that will evaluate the safety and effectiveness...
Neuspera announces first successful Nuvella system implant in second phase of...
Neuspera Medical has announced the first patient has been successfully implanted with the Nuvella system in its pivotal SANS-UUI clinical trial, which will evaluate...
IRRAS announces educational webinar series alongside Jacobs Institute and University of...
IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...
Researchers develop injectable biomaterial with potential in endovascular aneurysm treatment
Researchers in the USA have developed an injectable, ‘toothpaste-like’ biomaterial that may offer promise in the treatment of intracranial aneurysms as an alternative to...
Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses...
Process times and regional variation are main areas of concern for...
Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...
NICO announces completed enrolment in trial evaluating new ICH intervention approach
NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...
Physicians should prioritise first-pass optimisation over speed in thrombectomy procedures
Achieving clot retrieval with the fewest possible number of passes is critical in mechanical thrombectomy, and may even hold greater importance than how quickly...
Nevro announces first global manufacturing operation with Costa Rica expansion
Nevro Corporation announced recently that the US Food and Drug Administration (FDA) has approved its manufacturing operations in Costa Rica for the production of its proprietary...
US study bolsters recent evidence supporting tenecteplase in ischaemic stroke care
Tenecteplase, a newer-generation intravenous thrombolysis (IVT) drug, has outperformed the traditional treatment (alteplase) for ischaemic strokes in several key areas, demonstrating better health outcomes...
NeuroNews’ top 10 most popular stories of September 2022
The latest and greatest in neurointerventional clinical research buzzed our readers in September, with new studies on dual antiplatelet therapy (DAPT) duration, radial versus...
Microvention celebrates 25 years in neuroendovascular technologies with ‘Patient’s Day’
Microvention, a wholly owned subsidiary of Terumo Corporation, today celebrated its 25-year anniversary in the neuroendovascular technologies industry.
The capstone of Microvention’s 25th anniversary celebration...
Wallaby/phenox officially announces global launch of Pegasus HPC stent system
Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...
HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial
In the randomised HD-RECOVERY clinical trial, the use of high-definition transcranial direct current stimulation (HD-tDCS) has been found to be associated with a statistically...
Magnus receives US FDA clearance for SAINT neuromodulation system in severe...
Magnus Medical has announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its SAINT neuromodulation system for the treatment of...
Flow diverting, stenting and beyond—HPC technology offers “limitless” potential in neurointervention
This advertorial is sponsored by phenox.
Following the publication of a study assessing the use of Hydrophilic Polymer Coating (HPC) technology with the p64 MW...
UK NICE publishes interventional procedure guidance for ReActiv8 restorative neurostimulation
Mainstay Medical has announced that the National Institute for Health and Care Excellence (NICE), a public body of the UK Department of Health, has...
SWIFT-DIRECT sub-analysis finds effect of bridging thrombolysis is preserved over time
A recent sub-analysis of the SWIFT-DIRECT trial, which is published in the Journal of NeuroInterventional Surgery (JNIS), has found “no evidence” that the effect...
Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine
Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...
Vesalio announces US FDA approval of NeVa VS to treat cerebral...
Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...
Similar complication rates observed following DAPT discontinuation within and past 90...
The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...
Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system
Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...
Sheba and Thomas Jefferson to build “state-of-the-art” neuroscience centre in Israel
Sheba Medical Center, which is located in Ramat Gan, Israel and claims to be the country’s largest medical centre, has announced a major collaboration...
The inevitable growth of neurovascular robotics: Improved precision today, potential remote...
This advertorial, sponsored by Siemens Healthineers, is intended for readers outside of the USA.
The majority of cases the CorPath GRX Neurovascular Robotic System (Siemens...
Adjunctive therapy demonstrates comparable aneurysm occlusion rates to established flow diverters
The Neqstent coil-assisted flow diverter (Cerus Endovascular) has demonstrated comparable occlusion rates to those seen with other, similar flow diversion technologies, as well as...
Onward reports positive study results in restoring arm and hand function...
Onward Medical recently announced that the Up-LIFT pivotal study evaluating its non-invasive spinal cord stimulation (SCS) ARC-EX therapy achieved its primary effectiveness endpoint of...
CorPath GRX robot demonstrates safety and effectiveness in neurovascular aneurysm treatment
Corindus, a Siemens Healthineers company, announced today the recent presentation of results from a “first-of-its-kind” study demonstrating the safety and effectiveness of robotic-assisted neurovascular...
Increased coiling rate suggests shift towards endovascular techniques during COVID-19 pandemic
A global study published in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP) has revealed that, while ruptured aneurysm clipping rates remained largely unchanged,...
How AI, automation, robotics and other innovations in ultrasound are improving...
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
Axonics announces first patient implants in Canada with recharge-free sacral neuromodulation...
Axonics has announced the first patient implants in Canada with Axonics F15, the company’s newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system.
The University...
Basecamp Vascular announces first-in-human cases with steerable mechatronic guidewire
Basecamp Vascular (BCV) has announced a “major step” in the development and evaluation of steerable mechatronic guidewires for stroke treatment via its GECKO system....
Self-administered tDCS reduces knee osteoarthritis pain in older adult patients
Home-based, self-administered transcranial direct current stimulation (tDCS) has demonstrated feasibility, acceptability and significant reductions in clinical pain intensity in older adults with knee osteoarthritis,...
Penumbra announces European launch of RED reperfusion catheters for stroke care
Penumbra announced today that its RED reperfusion catheters have secured a CE mark and are now commercially available in Europe. The catheters are part of...
Isil Saatci
Isil Saatci has been practising interventional neuroradiology (INR) in Ankara, Turkey for almost the entirety of her career—initially at Hacettepe University, where she also...
Nevro announces positive coverage updates for treatment of painful diabetic neuropathy...
Nevro Corporation has announced that US health plan Aetna has updated its spinal cord stimulation (SCS) coverage policy to explicitly cover painful diabetic neuropathy...
Insightec announces financing up to US$200 million to support continued growth
Insightec has announced that it has signed a credit facility for up to US$200 million with affiliates of existing shareholders, Perceptive Advisors and Community Fund....
NeuroNews’ top 10 most popular stories of August 2022
In August, NeuroNews’ most read stories included new clinical data on a number of neurovascular technologies, physician viewpoints on a “historic” neurointerventional procedure in...
Neurofenix completes US$7 million Series A funding for digital stroke and...
Neurofenix has raised US$7 million in Series A funding via a round led by AlbionVC, with additional participation from HTH, InHealth Ventures, and existing...
Brainomix awarded tender to roll out AI imaging software across all...
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
Vesalio gains CE-mark approval for new “one-of-a-kind” NeVa NET thrombectomy device
Vesalio has today announced receipt of CE-mark approval for commercialisation of its new NeVa NET, which the company claims is the “first and only”...
Gimer Medical granted IDE approval for spinal cord stimulation system
Gimer Medical today announced that the company’s spinal cord stimulation (SCS) system was granted conditional investigational device exemption (IDE) approval by US Food and...
NeuroNews issue 47 – US
Highlights:
Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...
NeuroNews issue 47 – EU
Highlights:
Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...
New-look ESMINT congress to reflect on ISAT study and prioritise international...
After a long period of uncertainty triggered by a worldwide pandemic, the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September,...
Abnormal DW-MRI foci “significantly more frequent” with radial versus femoral access
A prospective analysis of 200 consecutive diagnostic cerebral angiograms has indicated that the number of diffusion-weighted magnetic resonance imaging (DW-MRI) restriction foci was “significantly...
Theranica secures US$45 million through Series C funding round
Theranica has announced the closing of its Series C funding round, with a first closing of US$45 million. New Rhein Healthcare Investors led the...
CereVasc announces first treatment in US trial evaluating eShunt for normal-pressure...
CereVasc today announced completion of the first eShunt procedure in the USA as part of a pilot study involving normal-pressure hydrocephalus (NPH) patients.
The study is being conducted...
MicroPort Neurotech receives Japanese marketing approval for Numen coil embolisation system
MicroPort Neurotech today announced that it has received marketing approval issued by the Ministry of Health, Labour and Welfare of Japan for its independently...
AiM unveils prototype of MRI-compatible neurosurgical robot, receives Sontag Foundation funding
AiM Medical Robotics has announced the unveiling of a magnetic resonance imaging (MRI)-compatible prototype of its “industry-first” robotics platform, a company press release states,...
First US Stentrode implant heralds new field in neurointerventional surgery
Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...
New data demonstrate effectiveness of Penumbra system and RED catheters for...
Penumbra today announced initial INSIGHT registry data showing that its RED reperfusion catheters were successful in removing all clot types—and, additionally, results of sub-analyses...
Imperative Care announces positive, single-centre data on distal occlusion stroke treatment
Imperative Care recently announced that new data evaluating the utility of its Zoom stroke solution were presented at the 16th congress of the World...
IRRAS announces first patient treatments in DIVE study at Mount Sinai...
IRRAS has announced the initial patient treatments with the company's IRRAflow system within Mount Sinai Health System (New York, USA).
Thus far, two patients suffering...
Abbott gains US FDA approval for Proclaim Plus spinal cord stimulation...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its new Proclaim Plus spinal cord stimulation (SCS) system featuring FlexBurst360...
Ybrain receives Translational Research Award for tDCS technology
Ybrain recently received the Translational Research Award at this year's Neuroergonomics and NYC Neuromodulation Conferences (28 July–1 August, New York City, USA) for its transcranial direct...
J Mocco becomes 27th Society of NeuroInterventional Surgery president
J Mocco, an endovascular neurosurgeon at Mount Sinai in New York City, USA has been named the 2022 president of the Society of NeuroInterventional...
Progress update on Women in Neuromodulation: Achievements and obstacles
In light of recent progress made in alleviating gender disparities within the neuromodulation field, Magdalena Anitescu (Chicago, USA), Anne Fennimore (Boca Raton, USA), Kiran...
Minnetronix makes “world’s first” expandable brain port available to neurosurgical markets
Minnetronix Medical’s first product, which the company says was conceptualised, developed, US Food and Drug Administration (FDA)-cleared and manufactured internally, is now fully commercialised...
Randomised data support use of tDCS in Parkinson’s patients with Pisa...
Data from a randomised controlled trial (RCT), which have been published in Frontiers in Neurology, support the use of neuromodulation with transcranial direct current...
Vena Medical announces first global thrombectomy procedures with Balloon Distal Access...
Vena Medical has announced the successful treatment of the first five patients in the world using its Vena Balloon Distal Access Catheter (BDAC) at...
SNIS 2022: WEB flow diverter shown to be safe and effective...
The Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) saw research involving the Woven EndoBridge (WEB; Microvention/Terumo) device disclosed for the...
RAAS inhibitors shown to reduce risk of intracranial aneurysm rupture in...
A multicentre study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of renin-angiotensin-aldosterone system (RAAS) inhibitors—a...
SyncThink secures CE mark for EYE-SYNC digital health platform
SyncThink announced today that it has gained CE-mark certification for its EYE-SYNC technology, affirming conformity to the European Medical Device Regulation (MDR). EYE-SYNC will...
NeuroOne submits special 510(k) to US FDA for Evo sEEG electrode
NeuroOne Medical Technologies has announced the submission of a special 510(k) to the US Food and Drug Administration (FDA) for its stereoelectroencephalography (sEEG) electrode...
CereVasc announces US FDA approval for second IDE study of eShunt...
CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...
Taiwan’s FDA approves first autonomous neurosurgical navigation robot from Brain Navi
NaoTrac, a CE-certified neurosurgical navigation robot from Brain Navi Biotechnology, has achieved approval from Taiwan's Food and Drug Administration (TFDA), and submission to the...
Phase one winners announced in US$9.8 million Neuromod Prize competition
The National Institutes of Health (NIH) Common Fund has named eight winners of the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate...
NeuroNews’ top 10 most popular stories of July 2022
Updates from two major neurointervention events, the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July 2022, Toronto, Canada) and LINNC Paris (30 May–1...
Silk Vista Baby demonstrates safety and effectiveness in PICA aneurysm treatment
Following a retrospective review of databases from multiple different centres, researchers have reported the safe and effective use of the Silk Vista Baby (Balt)...
Abbott introduces Canada’s first remote neuromodulation patient-care technology
Abbott recently announced the Health Canada licensing of NeuroSphere virtual clinic, a remote programming technology that the company claims is the first of its kind...
SNIS 2022: Late-breaking data bolster evidence supporting thrombectomy for BAO stroke
Late-breaking research presented at the recent Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) has shown that thrombectomy procedures can...
Stroke Association calls for 24/7 thrombectomy service across the UK
A new report released by the UK Stroke Association warns that, if thrombectomy rates remain at 2020/21 levels, a total of 47,112 stroke patients...
SNIS 2022: COVID-19 may increase stroke risk in younger patients and...
Stroke patients with COVID-19 are facing worse outcomes, and are often younger and healthier, according to research presented recently at the Society of NeuroInterventional...
SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...
SNIS 2022: Direct triage to Level 1 stroke centres reduces time...
Implementing severity-based field triage leads to faster treatment and less disability for stroke patients, according to late-breaking research presented recently at the Society of...
SNIS 2022: Neuroendovascular robotics could improve safety of complex procedures
Stroke surgery and other neuroendovascular procedures could be made safer and easier through robotics, according to research presented at the Society of NeuroInterventional Surgery’s...
Imperative Care announces positive real-world data associated with Zoom stroke solution...
Imperative Care has announced that new data from studies evaluating the utility of its Zoom stroke solution were recently presented at the ongoing Society...
Mitchell Elkind to join AHA leadership team as chief clinical science...
The American Heart Association (AHA) has announced that Mitchell Elkind (Columbia University, New York City, USA), long-time volunteer of the organisation and renowned neurologist,...
Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...
Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
Rapid Medical gains US FDA clearance for “smallest and only” adjustable...
Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...
Route 92’s Monopoint operating platform shows 82% first-pass effect in independent...
Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...
RapidAI receives US FDA clearance for Rapid Hyperdensity
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...
“Spectacular” unilateral proptosis treatment receives LINNC Paris Best Case Award
An “interesting case” of unilateral proptosis in a 14-year-old girl, treated using a hybrid approach via direct external carotid artery (ECA) puncture, was presented...
New study to assess intracranial haemorrhage detection with flat-detector versus multi-slice...
The SPINNERS study, which has just been announced by Siemens Healthineers, will evaluate the diagnostic accuracy of non-contrast flat-detector computed tomography (CT) compared to...
Robotics, AI and other innovations in stroke and aneurysm care on...
Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...
Cerenovus announces clinical data and product showcases ahead of SNIS 2022
Cerenovus, part of Johnson & Johnson MedTech, will showcase its latest innovations in stroke care at the 2022 Society of NeuroInterventional Surgery (SNIS) annual...
Synchron announces first human brain-computer interface implant in the USA
Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure represents a significant technological milestone for scalable BCI devices...
Saluda Medical presents data on 24-month holistic response to spinal cord...
Saluda Medical has announced that Steven Falowski (Argires-Marotti Neurosurgical Associates of Lancaster, Lancaster, USA) recently presented late-breaking 24-month data from the company’s EVOKE study at...
Imperative Care announces poster presentations on Zoom stroke solution at SNIS...
Imperative Care has announced that new data from studies evaluating the utility of the Zoom stroke solution for the treatment of ischaemic stroke will...
NeuroNews’ top 10 most popular stories of June 2022
In-depth discussions regarding a “landmark” study in medium vessel occlusion (MeVO) stroke, and the first thrombectomy procedures with a novel balloon guide catheter device,...
Rare disease variant specific to East Asian patients increases post-EVT reocclusion...
Among people who received endovascular mechanical thrombectomy to remove a large vessel occlusion (LVO), those with a rare genetic disease variant found primarily in people...
Large-scale prospective studies required to elucidate antithrombotic medication outcomes
The world of interventional neuroradiology will likely need to follow the cardiology field and conduct large-scale prospective studies in order to move away from...
Abbott receives Breakthrough Device designation to explore DBS in managing severe...
Abbott recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to investigate the use of its deep brain...
NICO announces new distributor for neurosurgery markets in Australia and New...
NICO Corporation recently announced that it has partnered with Imedcare, an Australia-based supplier and distributor of devices, as its distributor for the neurosurgery markets in the medical...
NeuroOne announces first clinical case using Evo sEEG electrode technology
NeuroOne Medical Technologies today announced that the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode was recently performed by Robert Gross at Emory University in...
High-frequency SCS demonstrates “substantial improvement” in health-related quality of life outcomes
Nevro Corporation has announced that the complete 12-month results from the SENZA-PDN randomised controlled trial (RCT), including health-related quality of life outcomes in patients with...
Neuromod publishes new data showing improvement of tinnitus symptoms with bimodal...
Neuromod Devices has published the results of the company's TENT-A2 (Treatment evaluation of neuromodulation for tinnitus—stage A2) clinical trial in Scientific Reports via a...
NeuroVasc announces first patient treated in clinical trial evaluating novel stent...
NeuroVasc Technologies recently announced that the first patient has been treated in its US investigational device exemption (IDE) clinical study, the ENVI randomised controlled...
Sham-controlled studies indicate effectiveness of TMS for negative schizophrenia symptoms
A systematic review and meta-analysis published in Nature Schizophrenia has concluded that data from sham-controlled studies to date indicate the effectiveness of transcranial magnetic...
Current literature suggests promise held by electrical stimulation therapies for cerebral...
Electrical stimulation technologies, and in particular spinal cord stimulation (SCS) and sphenopalatine ganglion stimulation, offer a promising adjunct to existing therapies for cerebral vasospasm...
AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments
The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...
Tenecteplase shown to be effective for acute ischaemic stroke in large...
In what is claimed to be the largest stroke clinical trial ever run in Canada, researchers have shown that tenecteplase—a safe, well-tolerated drug commonly...
Alarming trends and alarmist myths: What is the link between COVID-19...
Over the course of the past two years, the accepted understanding of how COVID-19 spreads and functions has improved vastly, with preventative vaccines and...
COVID-19 “did not affect stroke care quality or outcomes” in largest...
In one of the first studies to investigate the overall quality of care and outcomes of stroke care for non-COVID-19 hospitalised patients during the...
Neuspera Medical announces second phase of SANS-UUI clinical trial with Nuvella...
Neuspera Medical recently announced it will begin enrolment in its pivotal clinical trial, SANS-UUI—a single-arm investigational device exemption (IDE) study that will enrol 145 patients...
Valencia Technologies announces first commercial implantation of eCoin tibial neurostimulator
Valencia Technologies Corporation has announced in a press release that it has completed the “world's first” commercial implantation of its eCoin leadless tibial neurostimulator,...
Stimwave announces sale of business and secures US$40 million in financing
Stimwave Technologies Incorporated (Stimwave) recently announced that it has reached an agreement to sell substantially all of its assets to Kennedy Lewis Management LP...
MicroTransponder raises US$53 million and appoints new CEO
MicroTransponder has closed an oversubscribed US$53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and...
Neuromodulation offers hope for patients with long-COVID
With increasing focus being placed on the long-term impact COVID-19 can have, and the demand for effective treatments also growing concurrently, Marom Bikson (New...
Carthera receives FDA Breakthrough Device designation for Sonocloud-9 system
Carthera announced today that its Sonocloud-9 system has been listed as a Breakthrough Device by the Center for Devices and Radiological Health (CDRH) at...
MIVI Neuroscience names Waleed Brinjikji as new medical director
Next-generation neurointerventional medical device innovator MIVI Neuroscience has announced that Waleed Brinjikji (Mayo Clinic, Rochester, USA) has joined the company as its medical director.
“The...
Carotid stenting demonstrates comparable short- and long-term results to endarterectomy
Pooled patient-level data from more than 2,500 asymptomatic, non-octogenarian subjects have shown that carotid artery stenting (CAS) achieved comparable short- and long-term results to...
Pedro Lylyk
Pedro Lylyk’s work and achievements in the neurosurgical field have spanned several decades, and range from a momentous intracranial stent placement in 1996, to...
INS 2022: Late-breaking research indicates safety of deep brain stimulation in...
Deep brain stimulation (DBS) offers a safe therapy option for reducing chorea in patients with Huntington’s disease, but it remains to be seen whether...
First Emboguard experiences reveal “excellent trackability and ease of use” in...
Having been launched earlier this year, the Emboguard balloon guide catheter (Cerenovus) was recently used in mechanical thrombectomy procedures for the first time. David...
Artio Medical closes US$28 million in additional Series A financing
Artio Medical today announced the closing of US$28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised by the company to...
Silk Road to evaluate TCAR in standard surgical risk patients with...
Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularisation (TCAR) system in the treatment of standard surgical risk patients...
INS 2022: Occipital nerve stimulation shows clinical benefit and safety in...
A randomised controlled trial (RCT) presented at the International Neuromodulation Society (INS) congress (21–26 May 2022, Barcelona, Spain) has demonstrated significant and clinically relevant...
AHA statement highlights need for more data on sex differences in...
A new American Heart Association (AHA) scientific statement has highlighted the need for more data about sex differences in the use of and response...
Multicentre study indicates WEB flow disrupters can safely be used in...
As per the findings of a multicentre, retrospective study, use indications for the Woven EndoBridge (WEB) intrasaccular flow disruption device (Microvention/Terumo) can be safely...
High responder rates, substantial pain relief and no explants among key...
Nevro Corporation has announced the results from data presentations at the American Diabetes Association (ADA) 82nd Scientific Sessions (3–7 June 2022, New Orleans, USA) supporting the use of...
It takes two: The benefits of direct ‘double stentriever’ thrombectomy in...
This advertorial, sponsored by Medtronic, is intended for readers outside of the USA.
Mechanical thrombectomy may be the standard of care for acute ischaemic strokes...
MindMaze and University of Auckland partner on trial evaluating immersive intervention...
MindMaze—in partnership with the University of Auckland (Auckland, New Zealand)—has announced a new study that will aim to show the merits of early, immersive...
Multisession tDCS alongside cognitive remediation promotes social functioning in autism patients
In a randomised, sham-controlled clinical trial, multisession transcranial direct current stimulation (tDCS) paired with concurrent cognitive remediation training has been shown to promote social...
Route 92 publishes data demonstrating 80% first-pass effect with novel thrombectomy...
Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint...
Neuros Medical announces completion of 90-day primary endpoints in QUEST pivotal...
Neuros Medical has announced the completion of its QUEST pivotal trial’s 90-day primary endpoints, according to a company press release. QUEST outcomes will remain...
NeuroNews’ top 10 most popular stories of May 2022
A myriad of potentially groundbreaking clinical trials were in focus on NeuroNews throughout the month of May. A novel device in pain management, a...
Research indicates low stroke risk and benefit of medication alone in...
The risk of having a future stroke caused by asymptomatic carotid stenosis is “so low” that most patients with this condition could potentially be...
Axonics files FDA premarket approval supplement for fourth-generation rechargeable neurostimulator
Axonics has filed a premarket approval (PMA) supplement with the US Food and Drug Administration (FDA) for its fourth-generation rechargeable sacral neuromodulation (SNM) implantable...
Rapid Medical begins enrolment in DISTALS trial treating new ischaemic stroke...
Rapid Medical announced today the enrolment of the first patient in the DISTALS study, which the company claims is the first-ever US Food and...
Nevro announces upcoming presentation of new SENZA-PDN clinical data
Nevro Corporation has announced that data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—which the company says is the largest RCT to...
DISTAL: A landmark trial looking to elucidate endovascular treatment outcomes in...
In December 2021, University Hospital Basel (Basel, Switzerland) enrolled the first patient worldwide in the DISTAL study—a multicentre randomised controlled trial (RCT) evaluating the...
INS 2022: Dorsal horn dendrite stimulation offers “true breakthrough” in pain...
A novel approach to spinal cord stimulation (SCS), which involves targeting the dorsal horn dendrite—in contrast with more traditional ‘axonal’ SCS techniques—has been labelled...
Neuromodulation for post-stroke recovery advancing on several fronts
As a principal investigator for the pivotal VNS-REHAB study, which supported the first US Food and Drug Administration (FDA) premarket approval of a vagus...
Charing Cross audience as-yet unconvinced by data supporting transcarotid artery revascularisation
Audience polling during the Acute Stroke Challenges session at this year’s Charing Cross Symposium (CX 2022; 26–28 April, London, UK and virtual) revealed scepticism...
NeuroNews issue 46 – US
Highlights:
Late-breaking presentations from the European Stroke Organisation Conference (ESOC) progress clinical data on tenecteplase as an alternative intravenous thrombolysis drug to alteplase, and the...
NeuroNews issue 46 – EU
Highlights:
Late-breaking presentations from the European Stroke Organisation Conference (ESOC) progress clinical data on tenecteplase as an alternative intravenous thrombolysis drug to alteplase, and the...
Neuro42 licenses robotic technology from Johns Hopkins University
Neuro42 has announced an exclusive licensing agreement with Johns Hopkins University (Baltimore, USA) for its magnetic resonance (MR)-compatible robot for head, neck and spine...
Treating chronic-stage stroke with hyperbaric oxygen therapy
Mohammed Elamir (The Villages, USA) and Amir Hadanny (Be'er Ya'akov, Israel) mark this year’s Stroke Awareness Month by discussing hyperbaric oxygen therapy (HBOT)—an emerging...
Adept announces Prone Support product launch
Adept Medical says it has responded to the call from interventional radiologists for a device to comfortably support and manage a patient in the...
Vesalio announces oversubscribed Class A financing
Vesalio recently announced that it has oversubscribed its Class A financing round. Solas BioVentures led the investment with participation by new and existing investors,...
ESOC 2022: New study links gut microbiota strains with more severe...
A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut...
FDA approves launch of “largest clinical trial to date” for tDCS...
Flow Neuroscience, which claims to be the creator of Europe’s first medically approved brain stimulation device to treat depression at home, has received full...
Medtronic announces first implant in study evaluating investigational, closed-loop neurostimulator
Medtronic today announced the first patient implant in a clinical study of its investigative, closed-loop, implantable neurostimulator. The ‘Evaluation of long-term patient experience with...
Stroke in young people may be associated with increased likelihood of...
The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...
First commercial Vivistim patient set to begin paired vagus nerve stimulation...
MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...
Vesalio announces completion of enrolment in acute ischaemic stroke IDE study
Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...
STAR network and Avail Medsystems partner to aid remote physician collaboration
Avail Medsystems has announced that it has entered into a partnership with the Stroke Thrombectomy and Aneurysm Registry (STAR), led by Alejandro Spiotta (Medical...
Dolphin vagal nerve stimulator gains Health Canada nod for ‘long-haul’ COVID-19...
Health Canada recently authorised the Dolphin vagal nerve stimulator to treat symptoms in patients with COVID-19 ‘long-haul’ symptoms (long haulers). Long haulers experience a wide variety of aftereffects...
NeuroNews’ top 10 most popular stories of April 2022
Novel neurovascular technologies, from robotics, to microcatheters, to artificial intelligence (AI), were among the hottest topics featured on NeuroNews in April. A momentous company...
Synchron enrols first patient in US COMMAND study of endovascular brain-computer...
Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...
ATTENTION results indicate “we have finally conquered the basilar artery” with...
This year’s European Stroke Organisation Conference (ESOC 2022; 4–6 May, Lyon, France) saw results from ATTENTION—a multicentre randomised controlled trial (RCT) evaluating the benefit...
Artificial intelligence tutoring outperforms expert instructors in neurosurgical training
Against the backdrop of remote learning technologies becoming increasingly important within medical training during the COVID-19 pandemic, a new study has found that—in a...
Carotid stenosis in women: Should the approach differ?
The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...
NeuroPace announces first treatment in pivotal study evaluating RNS system in...
NeuroPace has announced that the first patient was recently treated in the RESPONSE clinical trial, which is evaluating the safety and effectiveness of the...
ESOC 2022: ‘Brain-age’ biomarkers predict stroke recovery more accurately than chronological...
Stroke experts have identified how radiomics—an emerging, image-quantifying technology—can be used to extract biomarkers from clinical brain magnetic resonance imaging (MRI) scans in stroke...
Study findings encourage direct EVT approaches over bridging thrombolysis in select...
A retrospective study involving more than 200 patients has indicated that ‘bridging thrombolysis’ may not be associated with improved functional outcomes in stroke patients...
Millimetric implant offers promising alternative to opioids or surgery in pain...
Using a one-millimetre-sized wireless implant to stimulate peripheral nerves from within blood vessels has the potential to treat neuropathic pain that is resistant to...
“Largest ever” study on traumatic brain injury highlights global inequality in...
Neurosurgery experts from the University of Cambridge (Cambridge, UK) have led what is claimed to be the largest ever study examining the surgical management...
Recommended use of SCS in neuropathic pain has not led to...
Only a small proportion of neuropathic pain patients in England who are potentially eligible for spinal cord stimulation (SCS) have received this intervention over...
Avicenna.AI signs distribution agreement with Sectra for neurovascular AI solutions
Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI...
Baptist Health South Florida to acquire ZAP-X gyroscopic radiosurgery platform
ZAP Surgical Systems announced today that Baptist Health South Florida (Miami, USA) will acquire the ZAP-X gyroscopic radiosurgery platform for cranial stereotactic radiosurgery (SRS)....
First patient treated in clinical trial of CereVasc’s eShunt system for...
CereVasc has announced treatment of the first patient in its clinical study of the eShunt system in patients with normal-pressure hydrocephalus (NPH).
Following approval from Argentina's...
MIT engineers develop joystick-operated robot to help surgeons treat stroke remotely
Engineers from the Massachusetts Institute of Technology (MIT) in Cambridge, USA have developed a telerobotic system to enable surgeons to quickly and remotely treat...
GT Medical Technologies to present clinical data on GammaTile brain tumour...
GT Medical Technologies announced today that new data on the company's innovative GammaTile therapy for patients with operable brain tumours will be presented via...
Medtronic names Laura Mauri as new chief scientific, medical and regulatory...
Medtronic has announced that Laura Mauri has been appointed as the company’s chief scientific, medical and regulatory officer. This appointment adds to Mauri's prior responsibilities...
Abbott upgrades NeuroSphere myPath app for patient monitoring in neuromodulation trials
Abbott today announced that it has launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality intended to help doctors...
International Neuromodulation Society announces “Innovations in Neuromodulation” event at May congress
With an educational event entitled “Innovations in Neuromodulation”, the International Neuromodulation Society (INS) will attempt to bring together industry leaders, innovators and investors to...
Microvention announces enrolment of first patient in STRAIT study evaluating new...
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the successful completion of its first patient enrolment in a multicentre, prospective, observational study...
Stimwave launches FREEDOM series with trial evaluating PNS in chronic knee...
Stimwave Technologies has announced the launch of its level-one FREEDOM clinical trial series—which consists of multicentre, prospective, randomised trials that monitor chronic pain patients’...
Wallaby acquires phenox to accelerate global expansion in neurovascular space
Wallaby Medical today announced that it has acquired phenox GmbH—including phenox's femtos GmbH—for a total consideration of approximately €500 million including milestone payments.
The acquisition is...
Women less likely to return to work after severe stroke, new...
According to new research published in Stroke, about one third of people who had a severe ischaemic stroke—and underwent a mechanical thrombectomy to remove...
UK stroke patients among thousands left waiting more than one hour...
In March 2022, more than 390,000 people who called 999 with emergencies including suspected stroke waited for an average of over one hour for...
NeuraLace announces two new patents for Axon neuropathic pain therapies
NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of two new patents: US Patent No. 11,305,130 for "Devices, systems,...
Axonics announces comprehensive launch of F15 recharge-free SNM system
Axonics today announced the comprehensive launch of the Axonics F15 across the USA. The newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system also...
Bendit receives FDA 510(k) clearance for 0.021-inch steerable microcatheter
Bendit Technologies has received US Food and Drug Administration (FDA) 510(k) clearance of its Bendit21 microcatheter for treatment in the neuro, peripheral and coronary...
Preliminary data indicate improved neurological outcomes with alteplase versus placebo
As per early findings from the CHOICE randomised controlled trial (RCT), the use of adjunct, intra-arterial alteplase—among patients with large vessel occlusion (LVO) acute...
Corindus relocates Massachusetts headquarters to accommodate company growth
Corindus, a Siemens Healthineers company, announced today the opening of its new headquarters at 275 Grove Street in Newton, USA. Siemens Healthineers relocated the...
CX 2022: Acute stroke programme seeks to evaluate study data and...
Barbara Rantner (Munich, Germany) previews the Acute Stroke Challenges programme at CX 2022—a two-hour session featuring several debates and audience polls on carotid disease...
Viz.ai raises US$100 million in Series D funding to expand AI...
Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, as per a company press release. The Series D round, which...
Michael Chen
Michael Chen—a neurointerventionist and professor of Neurology, Neurosurgery and Radiology at Rush University Medical Center in Chicago, USA—speaks to NeuroNews to provide insight on...
Guidewire-less neurovascular navigation system shows promise in rabbit aneurysm model
A new concept for navigating the neurovasculature, performed without the aid of a guidewire, has demonstrated its ability to be manoeuvred through tortuous vessels,...
Aidoc gains FDA 510(k) clearance for AI-supported triage and notification of...
Aidoc has received US Food and Drug Administration (FDA) 510(k) clearance for the triage and notification of brain aneurysm—which affects one in 50 people...
NeuroNews’ top 10 most popular stories of March 2022
Industry-fronting experts from the worlds of neurointerventional surgery and neuromodulation alike weighed in on a number of key topics throughout the month of March....
Cefaly publishes study data indicating effectiveness of e-TNS migraine treatment
Cefaly Technology has announced the results of a clinical study demonstrating that two-hour treatment with its external trigeminal nerve stimulation (e-TNS) Cefaly device is...
Study data indicate positive outcomes with “exciting new treatment option” in...
Data from a multicentre clinical study supporting the use of Anaconda Biomed’s Advanced Neurovascular Access (ANA) catheter system for treating ischaemic stroke have been...
London clinic becomes first in UK to offer new drug-free Alzheimer’s...
The London Alzheimer’s Clinic on Harley Street (London, UK) has become the first clinic in the UK to offer transcranial pulse stimulation (TPS)—a “revolutionary”...
Why robotics holds the key to the future of stroke treatment
Vitor Pereira and Nicole Cancelliere (St Michael’s Hospital, Toronto, Canada) outline recent breakthroughs in the deployment of robotics for neurointerventional procedures and discuss future...
Radial access is not just a new toy—it has come to...
This advertorial is sponsored by Medtronic.
Upon gaining CE-mark approval in September of last year, the Rist radial access system (Medtronic) became the first dedicated...
Biomodex launches clear cartridges for neurovascular surgery training
Biomodex has announced the launch of new clear cartridges for use with all of its EVIAS (Endovascular intracranial aneurysm system) and EVIAS Plus stations for preprocedural...
NeuroNews issue 45 – US
Highlights:
Japanese study—first presented at the International Stroke Conference (ISC)—sheds light on mechanical thrombectomy in severe ischaemic stroke patients
The pros and cons of...
NeuroNews issue 45 – EU
Highlights:
Japanese study—first presented at the International Stroke Conference (ISC)—sheds light on mechanical thrombectomy in severe ischaemic stroke patients
The pros and cons of...
Implantable brain-computer interface enables completely locked-in patient to communicate
Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...
Synchron announces long-term safety results with Stentrode device for severe paralysis
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...
Sonocloud technology demonstrates safety and therapeutic potential in Alzheimer’s patients
Carthera has announced today the publication of results from an investigator-sponsored pilot clinical trial evaluating safety and efficacy using its Sonocloud technology in patients...
Cerus Endovascular receives FDA clearance for 027 microcatheter products
Cerus Endovascular has received US Food and Drug Administration (FDA) 510(k) clearance for its 027 microcatheters, available in two lengths, expanding on a product...
Survey uncovers “far-reaching” impact of pandemic on patients with chronic back...
A new survey commissioned by Medtronic and conducted by public opinion research firm The Harris Poll has found that 44% of current chronic back...
Medtronic announces first patient implants of investigational TNM therapy for bladder...
Medtronic recently announced the first patients have been implanted in the TITAN 2 pivotal study—which will evaluate the safety and efficacy of its investigational...
High-frequency SCS drives impactful outcomes for non-surgical refractory back pain patients
Following the recent introduction of key data supporting the use of high-frequency spinal cord stimulation (SCS) in the treatment of non-surgical refractory back pain...
AAN issues new guidance on preventing second stroke in patients with...
In patients with intracranial atherosclerosis, the use of medications and exercise is more beneficial in preventing a second stroke than placing a stent in...
Stimwave Technologies provides update on reimbursement of chronic pain therapies
Stimwave Technologies has provided an update on recent reimbursement-related progress pertaining to its chronic pain therapies—which include implantable spinal cord stimulation (SCS) and peripheral...
AiM Medical Robotics raises US$3.4 million to accelerate MRI-compatible robotics platform
AiM Medical Robotics recently announced that it has raised US$3.4 million in seed funding, led by IQ Capital and Surrey Capital Partners. Other investors include The...
Zeta Surgical secures US$5.2 million to enhance AI-driven neurosurgical technologies
Zeta Surgical has announced the close of US$5.2 million in seed financing—and will use these funds to finalise development of its neurosurgical navigation platform, Zeta,...
Pushing the boundaries of aneurysm detection, monitoring and care with AI
Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be the next frontier in cerebral aneurysm care—artificial intelligence (AI)—and...
Lower frequencies may improve outcomes of pain treatment with dorsal root...
Lower frequencies of dorsal root ganglion stimulation (DRG-S) may be more effective in the treatment of neuropathic pain—as per a late-breaking presentation from Guilherme...
The pros and cons of radial access in neurointerventional surgery
As the adoption of radial access across the world of neurointerventional surgery begins to pick up pace, Pascal Jabbour and Kareem El Naamani (Thomas...
Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas
A new strategy using telehealth to monitor blood pressure at home for several months immediately after a stroke had a positive impact on patient engagement and blood...
Multiple daily doses of iTBS provide no additional benefit in treatment-resistant...
In patients with treatment-resistant depression (TRD), multiple sessions of intermittent theta-burst stimulation (iTBS) do not accelerate responses to the therapy, nor do they improve...
PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment
PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...
New technology enables option for neurosurgeons to avoid pinning patients’ heads...
Following the introduction of its BrainPath navigation probe adapter at the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA), medical device innovator NICO Corporation claims...
Axonics receives FDA approval for new recharge-free sacral neuromodulation system
Axonics has announced that the US Food and Drug Administration (FDA) has approved its newly developed, long-lived, recharge-free sacral neuromodulation (SNM) implantable neurostimulator, the...
Rapid Medical announces Eitan Havis as international president
Rapid Medical has announced the promotion of Eitan Havis to international president of the company. Havis will oversee the commercial expansion of the company’s advanced neurovascular...
Valencia Technologies announces FDA approval of eCoin therapy for urinary urge...
Valencia Technologies Corporation has announced that the US Food and Drug Administration (FDA) has granted premarket approval of its eCoin leadless tibial neurostimulator for...
AI, cost reductions and more represent bright future for neuromodulation industry
On technological and commercial fronts alike, the neuromodulation space is one of the more rapidly evolving subsectors within the medical industry—and has undergone a...
Registration opens for 15th International Neuromodulation Society congress in Barcelona
At the International Neuromodulation Society (INS) 15th world congress (21–26 May 2022; Barcelona, Spain), researchers from over 40 countries will present plenary lectures and...
Multiple-modality spinal cord stimulation demonstrates sustained improvement in chronic pain outcomes
A spinal cord stimulation (SCS) system capable of simultaneously delivering multiple treatment modalities has produced a sustained improvement in outcomes in a randomised controlled...
NeuroNews’ top 10 most popular stories of February 2022
Highlights from the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA)—predominantly relating to mechanical thrombectomy studies—grabbed our readers’ attention throughout February. New...
NeuroOne releases successful completion of long-term stimulation tests with novel, thin-film...
NeuroOne Medical Technologies has announced that it successfully completed initial, bench-top, long-term stimulation testing on a novel design of its thin-film electrode technology. The...
First patient implanted in clinical study assessing hypoglossal nerve stimulation for...
LivaNova has announced the first patient has been implanted as part of an investigational device exemption (IDE) clinical study, dubbed OSPREY (Treating obstructive sleep apnea using...
Accuray announces NICE endorsement for radiosurgery treatment of trigeminal neuralgia
Accuray has announced that the National Institute for Health and Care Excellence (NICE) has endorsed the use of its radiosurgery technology for trigeminal neuralgia—strengthening...
Microvention announces treatment of first US patient with FRED X flow...
Microvention, a subsidiary of Terumo, has announced the first US clinical case using its next-generation flow diverter, the FRED X device, at Thomas Jefferson University Hospital...
Viz.ai receives FDA 510(k) clearance for cerebral aneurysm detection algorithm
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM—a new algorithm that uses artificial intelligence (AI) to detect suspected...
Lack of evidence among challenges that must be overcome to realise...
In spite of the clinical successes observed to date, a lack of high-level safety and efficacy evidence, among other current challenges and limitations, must...
FDA grants Aleva Neurotherapeutics approval for IDE study with directSTIM system
Aleva Neurotherapeutics has received a letter of approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) study assessing...
Medtronic receives FDA approval for InterStim X system for bladder and...
Medtronic has announced receipt of approval from the US Food and Drug Administration (FDA) for its new, recharge-free InterStim system—with the device being made...
Children with severe stroke may fare better if treatment includes mechanical...
Serious disability is six times more likely to be the result three months after stroke among children whose large-vessel stroke was not treated with...
Neuromod welcomes study demonstrating safety and efficacy of Lenire device in...
Neuromod Devices has welcomed the findings of an independent study performed at the German Hearing Center at Hannover Medical School (Hannover, Germany), which found...
ISC 2022: New study finds better outcomes in patients treated at...
When comparing outcomes for acute ischaemic stroke patients treated at various levels of stroke centres, patients who received care at comprehensive stroke centres (CSC) or thrombectomy-capable...
Single-patient study offers promise for individualised depression treatment with DBS
Despite its small sample size, a study in which a patient received closed-loop, deep brain stimulation (DBS) therapy has demonstrated positive clinical outcomes and...
Myopro shows clinically significant gains in motor function for chronic moderate-to-severe...
Myomo has announced that new research measuring the benefits of its Myopro myoelectric orthosis found “statistically significant improvements” in a number of motor function...
New player in stent retriever space demonstrates non-inferiority to Solitaire device
A relatively new introduction to the field of endovascular therapy (EVT) for acute ischaemic stroke, the Skyflow stent retriever (Skyflow), has demonstrated non-inferiority with...
Study shows positive impact of new in-app feature on Nerivio REN...
A new peer-reviewed study published in Pain Medicine, examining the use of Nerivio’s (Theranica) guided imagery, education and relaxation (GIER) in-app optional behavioural intervention...
Newer clot-busting medication may someday increase time window for stroke treatment
In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...
Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment
Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...
Imperative launches Zoom POD aspiration tubing for use in stroke treatments
Imperative Care has announced the launch of its Zoom POD aspiration tubing—the company’s latest innovation in elevating stroke care.
This is the newest addition...
Nevro announces publication of 12-month data on high-frequency SCS for non-surgical...
Nevro Corporation has announced online publication of 12-month data from the SENZA-NSRBP randomised controlled trial (RCT) in Journal of Neurosurgery: Spine. These data show that...
ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has...
Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...
NovaGuide intelligent ultrasound found to significantly improve right-to-left shunt detection
NovaSignal Corporation has announced the results of a multicentre, prospective, single-arm study indicating that the company’s autonomous NovaGuide intelligent ultrasound is three times more...
New data presented at ISC 2022 further validate real-world impact of...
Data from several new studies presented at the recent International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA) further validate the “best-in-class” sensitivity and...
NeuroOne releases successful long-term recording data with novel electrode technology
NeuroOne Medical Technologies has announced that it successfully completed initial preclinical, long-term testing of recording capabilities on its thin-film platform electrode technology.
In test...
Cerenovus launches Emboguard balloon guide catheter for acute ischaemic stroke
Cerenovus—a neurovascular firm that forms part of Johnson & Johnson Medical Devices Companies—has announced the launch of Emboguard, its next-generation balloon guide catheter to...
Mechanical thrombectomy shown to restore more function than medication alone following...
A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...
NeuroNews’ top 10 most popular stories of January 2022
An exclusive interview with the North American Neuromodulation Society (NANS) president piqued the interest of NeuroNews’ readers through the first month of the year,...
Perfuze raises €22.5m in Series A funding for novel acute ischaemic...
Perfuze announced today that it has closed a €22.5 million Series A investment round—the proceeds from which will be used to drive the next...
CereVasc receives FDA nod to study eShunt system in normal-pressure hydrocephalus...
CereVasc has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate a pilot trial...
Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...
Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...
Few cases and short timeframe required to overcome learning curve with...
A retrospective analysis of a prospectively maintained database has found that robot-assisted carotid artery stenting (CAS) is both safe and effective. Writing in Neurosurgical...
Intermittent theta-burst stimulation found to be effective and well-tolerated in Alzheimer’s...
The findings of a randomised controlled trial (RCT) have indicated that accelerated intermittent theta-burst stimulation (iTBS), administered to the left dorsolateral prefrontal cortex (DLPFC), is an...
Earl Slee joins Vesalio as new board observer and senior advisor...
Vesalio has announced the addition of Earl Slee as a board observer and senior advisor to the company, effective immediately. According to a company...
Vena balloon distal access catheter gains Health Canada medical device licence
Vena Medical has announced the first Health Canada medical device licence for its new product, the Vena balloon distal access catheter, which combines the...
Reducing disability and death: What is next for stroke triage and...
Michael Chen (Rush University Medical Center, Chicago, USA) discusses the growing awareness around the need for timely interventions in stroke care in the USA,...
Updated medical policy expands patient access to Abbott’s DRG stimulation technology
Abbott announced today that UnitedHealthcare (UHC)—the largest private health insurance company in the USA—has updated its ‘Implanted electrical stimulator for spinal cord’ medical policy...
Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment
Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...
Researchers pave way for adaptive DBS treatment after identifying OCD-associated brain...
In an effort to improve treatment for obsessive-compulsive disorder (OCD), a team of researchers has—for the first time, according to a Brown University (Providence,...
Galvani Bioelectronics announces first investigational treatment of rheumatoid arthritis using splenic...
Galvani Bioelectronics has announced that the first patient with rheumatoid arthritis (RA) has been treated through stimulation of the splenic nerve using its novel...
Rebus Esper platform leveraged to create “cell atlas” of brain vasculature...
Rebus Biosystems, an Illumina Ventures-backed life science technology firm, has announced the publication of a study in Science highlighting its Rebus Esper platform’s ability to spatially...
FDA issues two final guidances for including patient perspectives in medical...
The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.
As...
NANS 2022: New 18-month data show durability of high-frequency SCS for...
This year’s North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) saw 18-month data from SENZA-PDN—a randomised controlled trial (RCT) evaluating the...
Brainomix launches e-Stroke 11 to enhance stroke network communications and workflow
Brainomix has announced the launch of e-Stroke 11, the latest version of the company's AI-powered stroke imaging platform. According to a Brainomix press release,...
Salim Hayek
Salim Hayek is chief of the Division of Pain Medicine at University Hospitals of Cleveland and a professor in Case Western Reserve University’s Department...
Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research
Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...
NIH launches first phase of US$9.8 million competition to accelerate development...
The National Institutes of Health (NIH) has launched the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate the development of neuromodulation therapies....
Bendit announces first-in-human use of Bendit21 neurovascular catheter in the USA
Bendit Technologies has announced the successful first use in the USA of its Bendit21 neurocatheter in a life-saving treatment. The case was completed at the University...
Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal...
Fresh data from the CERUS study—the first multicentre clinical trial evaluating safety and effectiveness outcomes with the Contour neurovascular system (Cerus Endovascular)—have indicated “encouraging...
Large real-world analysis deems Nerivio safe and effective in migraine treatment
Theranica has announced a new peer-reviewed study analysing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication-adjunct, treatment...
Nevro announces clinical data reinforcing significant and durable benefits of 10kHz...
Nevro Corporation has announced the results from data presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) supporting...
Medtronic announces results showing meaningful pain relief using DTM SCS endurance...
Medtronic has announced three-month results from an on-label, prospective, multicentre study showing meaningful pain relief using DTM SCS endurance therapy—a modified, lower-energy variation of the...
NANS 2022: Telehealth to play key role in improving patient access...
COVID-19 may have held a defining role in the “rebirth” of telehealth and remote care models in the USA, but their utility in improving...
Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression
Stanford accelerated intelligent neuromodulation therapy (SAINT)—a novel, high-dose intermittent theta-burst stimulation (iTBS)—was found to be safe and more effective than sham stimulation in a...
American Academy of Neurology provides ethical guidance on consent for people...
The American Academy of Neurology (AAN) has issued a position statement for neurologists on how to navigate consent issues for people who have experienced acute ischaemic...
First patient implanted in integrated spinal fusion and DRG stimulation proof-of-concept...
SynerFuse has announced the first implantation in the company's proof-of-concept study evaluating the safety and tolerability of simultaneously implanting spinal fusion hardware and a dorsal...
Evasc Neurovascular announces enrolment of first patient in French eClips study
Evasc Neurovascular has announced enrolment of the first patient in its eClips safety, feasibility and efficacy study (EESIS-FR) in France. The study will be...
Dedicated primary care can reduce stroke risk in seniors by more...
ChenMed has announced results from a three-year study of nearly 60,000 patients, showing 22% lower incidence of primary stroke among those having benefitted from...
FDA grants Breakthrough Device designation to Wavegate for StimuLux system
Wavegate Corporation has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for its StimuLux optical reflectometry system for closed-loop...
Medtronic announces schedule for sponsored presentations at NANS 2022
Medtronic has announced its schedule for presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA). According to a press...
Study indicates aneurysm embolisation strategy can be optimised using 3D-printed, patient-specific...
Endovascular neurosurgery rehearsals using 3D-printed, patient-specific aneurysm models have demonstrated the ability to optimise embolisation strategy, as per the findings of a study published...
NeuroNews’ top 10 most popular stories of December 2021
In the lead up to the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA), the topic of neuromodulation featured prominently among...
Mainstay Medical announces positive efficacy and safety outcomes from ReActiv8-B trial
Mainstay Medical has announced the publication of two-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, which are published in Neuromodulation:...
Saluda announces sustained, long-term pain relief results with closed-loop SCS in...
Saluda Medical today announced long-term results from its double-blind, Level 1 EVOKE trial, which have been published in JAMA Neurology and demonstrate superior, sustained pain...
Boston Scientific to present new data on advances in chronic pain...
Boston Scientific has announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA)....
NeuroNews issue 44 – US
Highlights:
Insight from the "largest prospective study to date" of the p64 flow modulation device (phenox)
The latest clinical data on endovascular therapy for...
NeuroNews issue 44 – EU
Highlights:
Insight from the "largest prospective study to date" of the p64 flow modulation device (phenox)
The latest clinical data on endovascular therapy for...
iMediSync unveils “world’s first” integrated wireless brain EEG solution at Consumer...
iMediSync recently showcased its comprehensive electroencephalogram (EEG) solution, designed to perform brain screening and predictive analysis of potential mental conditions in just 10 minutes,...
Enabling new possibilities in stroke treatment with Stream technology
This advertorial is sponsored by Perflow.
The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...
Wallaby Medical launches Avenir coil system for haemorrhagic stroke treatment in...
Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....
Abbott announces expanded MRI compatibility for Proclaim XR spinal cord stimulation...
Abbott has announced that the US Food and Drug Administration (FDA) has approved new, expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR spinal cord...
Patient assent and lack of evidence among key ethical concerns identified...
A study intended to gain insight into prevailing ethical issues surrounding the use of deep brain stimulation (DBS) in adolescents with obsessive-compulsive disorder (OCD)...
Worldwide stroke rates dip slightly over time, but overall numbers remain...
The worldwide incidence and mortality rates for stroke decreased slightly from 1990 to 2019, but the overall numbers remain high—especially in high- and middle-income...
Current gaps and barriers in patient access to spinal cord stimulation
Maricela Schnur (St Luke’s Hospital, Duluth, USA) highlights a handful of socioeconomic disparities, racial differences, and psychological and psychiatric factors, that currently present difficulties...
CyberKnife robotic radiosurgery system approved for treatment of trigeminal neuralgia in...
Accuray has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market the CyberKnife robotic radiosurgery system for the treatment of...
BRAIN 2021: In silico clinical trials likely to play complementary role...
In silico studies involving virtual participants hold great potential in the neurovascular field—and the broader medical industry—with their future role in the generation of...
US physicians “among nation’s first” to implant neurostimulator technology for advanced...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technology in patients to help treat advanced heart failure—and are...
ClaroNav receives Chinese regulatory clearance for Navient neuro-navigation system
ClaroNav Kolahi—a subsidiary of ClaroNav—has received regulatory clearance from the National Medical Products Administration (NMPA) to market and sell its Navient cranial model in...
Time savings, cost reductions and improved patient outcomes all key benefits...
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy...
BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...
NeuroNews’ top 10 most popular stories of November 2021
The latest technologies and research breakthroughs in neuromodulation feature prominently among our top stories for November, while two momentous announcements from the neurosurgery field—courtesy...
Mouse study suggests neuromodulation of certain nerve cells can help regenerate...
Johns Hopkins Medicine researchers say they have new evidence from mouse experiments that manipulating certain nerve cells, or the genes that control them, with...
CereVasc announces publication of first-in-human case report with eShunt system
CereVasc has announced the publication of a case report detailing the first treatment in a study of its eShunt system—an investigational device intended to...
Passive recharge burst SCS provides sustainable improvements in pain and psychosocial...
Passive recharge burst spinal cord stimulation (B-SCS) can alleviate pain intensity and psychological distress, and improve physical function and health-related quality of life out...
MicroTransponder receives best new product award for Vivistim system
MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...
FluxWear to debut wearable neuromodulation device at 2022 Consumer Electronics Show
FluxWear has announced that it will be demonstrating its first product at the Consumer Electronics Show (CES) early next year (5–8 January 2022, Las...
AURORA: Evidence in favour of thrombectomy beyond six hours strengthened by...
Evidence favouring endovascular therapy (EVT) in anterior circulation stroke patients presenting with reversible cerebral ischaemia in the later time window (beyond six hours) from...
New protocol may reduce need for psychological assessments prior to neuromodulation...
Researchers at Toronto Western Hospital in Canada have proposed a protocol that may precede in-person assessments prior to patients receiving neuromodulation therapies. Their protocol...
Wyss Center, Inselspital Bern announce clinical trial of long-term brain monitoring...
As part of a recently announced clinical trial, brain signal recording with the Wyss Center for Bio and Neuroengineering’s novel brain-monitoring technology, its subscalp...
Nevro announces three key data publications on novel painful diabetic neuropathy...
Nevro has announced three clinical data publications on treating painful diabetic neuropathy (PDN) with 10kHz spinal cord stimulation (SCS) therapy—including 12-month data from the...
Incidence of brain complications among hospitalised COVID-19 patients revealed in global...
The largest multi-institutional international study to date on brain complications associated with COVID-19 has found that approximately one in 100 patients hospitalised following SARS-CoV-2...
White matter hyperintensities may hold key to identifying long-term harm in...
A new study has found that brain scans taken during the lifetimes of athletes in contact sports, compared to changes in their brains at...
Large prospective study demonstrates high efficacy and low mortality rates with...
The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...
Intranasal delivery of microrobots could trigger new possibilities in treating neurological...
A research team in South Korea has developed and successfully implanted a microrobot device into the brain tissue of mice through the intranasal pathway,...
SedLine-guided general anaesthesia may reduce post-carotid endarterectomy delirium
Masimo has announced the findings of a prospective study published in Frontiers in Neurology in which Na Xu and colleagues at Capital Medical University in Beijing,...
Antibiotic envelopes appear safe and effective in decreasing SCS surgical site...
Antibiotic impregnated envelopes appear to be a safe and effective modality for decreasing surgical site infection risks in spinal cord stimulation (SCS) implantation, according...
Robocath successfully performs first carotid stenting in France with R-One robot
Robocath today announced its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on 16 November...
Accuray announces two decades of clinical data on CyberKnife robotic radiotherapy...
Accuray has announced the publication of more than two decades of globally-driven clinical data supporting the use of its CyberKnife robotic radiotherapy platform for the delivery...
NeuroNews’ top 10 most popular stories of October 2021
New data on stroke rehabilitation and chronic migraine therapy caught the eye of NeuroNews' readers in October, as did notable discussions from industry-leading events...
Viz.ai debuts AI-powered cerebral aneurysm detection technology at SVIN 2021
At this year’s Society of Vascular and Interventional Neurology annual meeting (SVIN 2021; 17–20 November, Phoenix, USA and virtual), Viz.ai introduced Viz ANX, a...
BlueWind Medical completes patient enrolment in OASIS study
BlueWind Medical has announced the successful completion of patient enrolment in the OASIS pivotal clinical study that will assess the company’s innovative Renova iStim...
Hispanic stroke patients experience poorer post-thrombectomy outcomes than white counterparts
A study conducted by neurology researchers at University of Texas Southwestern (UTSW) Medical Center has found lower-quality functional outcomes for Hispanic ischaemic stroke patients...
Cascade device provides the best of both worlds in treating cerebral...
This advertorial is sponsored by Perflow.
The Cascade Net (Perflow)—a non-occlusive remodelling net used in the treatment of cerebral aneurysms—is the first and only device...
NeuroPace gains IDE approval to launch pivotal study of neuromodulation therapy...
NeuroPace has announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the NAUTILUS...
Research shows brain rhythm changes occur ‘within minutes’ of DBS surgery...
New research published in Translational Psychiatry presents evidence that brief intraoperative exposure to therapeutic deep brain stimulation (DBS) at the time of implantation surgery induces...
Insightec announces FDA approval of Exablate Neuro device to treat Parkinson’s...
Insightec has announced that the US Food and Drug Administration (FDA) has approved the Exablate Neuro device for treating advanced Parkinson's disease patients suffering from...
Return to work and depressive symptoms in young stroke survivors
Matthias Volz (University of Kassel, Kassel, Germany), Simon Ladwig and Katja Werheid (both Humboldt-Universität zu Berlin, Berlin, Germany) discuss the burden of post-stroke depression...
Nevro announces plans to appeal jury decision in spinal cord stimulation...
Nevro Corporation has provided an update on its position following a Delaware jury’s decision to award Boston Scientific US$20 million over patent infringements. The...
Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...
Rune Labs and Medtronic partner to improve understanding of neurostimulation with...
Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and global healthcare...
New study finds e-Stroke software shortens treatment times and improves functional...
A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...
Magnus Medical announces Breakthrough Device designation for novel depression treatment and...
Magnus Medical has announced that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device designation for its individualised, rapid-acting, non-invasive...
Increased experience associated with shorter procedure times and better reperfusion rates...
Increasing levels of experience in performing mechanical thrombectomies have been associated with shorter procedural duration and better reperfusion rates in a multicentre study—with the...
World Stroke Day 2021: Get Ahead of Stroke campaign pushes for...
On World Stroke Day—29 October 2021—physicians from the Get Ahead of Stroke campaign are urging lawmakers to update triage and transport protocols. They are...
World Stroke Day 2021: Survey finds 65% of hospitals worldwide do...
On the eve of World Stroke Day (29 October), the World Stroke Organization (WSO) has called for urgent improvements to the treatment of stroke...
Phenox expands acute ischaemic stroke portfolio with global launch of pRESET...
Phenox has added to its extensive technology portfolio with the introduction of the pRESET 6-50 mechanical thrombectomy device for the treatment of acute large...
Biomodex launches synthetic clot product for neurovascular training
Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...
SPR Therapeutics announces expanded FDA clearance for SPRINT peripheral nerve stimulation...
SPR Therapeutics has obtained clearance from the US Food and Drug Administration (FDA) of a broader indication for the usage of its SPRINT peripheral...
Study indicates safety and efficacy of remote electrical neuromodulation in chronic...
Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...
North Carolina updates stroke triage and transport protocol
North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...
Neuvotion secures more than US$1 million in seed funding to commercialise...
Neuvotion has announced that it has received more than US$1 million in seed funding. The Long Island Angel Network, an organised group of individual,...
MindMaze partners with Royal Buckinghamshire Hospital to bring novel stroke rehab...
MindMaze Healthcare has announced the first UK partnership for its novel MindPod platform to target cognitive and motor restoration in stroke patients. This new partnership...
NeuroNews’ top 10 most popular stories of September 2021
Highlights from this year's European Stroke Organisation Conference (ESOC 2021; 1–3 September, virtual), Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021;...
Imperative Care enrols first patient in trial evaluating Zoom 88 Large...
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
Wyss Center announces CE mark for Epios Cloud brain data visualisation...
The Wyss Center has announced CE mark Class I medical device approval for its Epios Cloud software—a web-based application for the online storage, processing...
NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...
NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...
Stroke study reveals optimal timing and intensity for arm and hand...
A phase II, randomised clinical trial has found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should...
High-frequency SCS takes the stage to relieve chronic pain from diabetic...
Following the recent approval of the Senza system (Nevro) by the US Food and Drug Administration (FDA), Erika A Petersen (Little Rock, USA) discusses the...
Medtronic receives CE mark approval for radial artery access portfolio
Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...
Indian health ministry approves Exablate Neuro focused ultrasound platform
Insightec has announced its incisionless neurosurgery platform, the Exablate 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO)—part of the Ministry...
Medtronic recalls Pipeline Flex embolisation devices over risk of delivery system...
Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...
FAST SCS innovation producing results “rarely seen before” in the world...
This advertorial is sponsored by Boston Scientific and is only intended for readers in Europe.
Fast-acting sub-perception therapy (FAST™)—a novel innovation in the field of...
NeuroOne successfully completes feasibility study of Evo ablation electrode
NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its combination recording and ablation technology at T3 Labs and...
LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with...
At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...
Else Charlotte Sandset
Else Charlotte Sandset is a consultant neurologist in the Stroke Unit of the Department of Neurology at Oslo University Hospital, and chair of the...
Rhaeos awarded US$4 million NIH grant to expand sensor technology for...
Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...
ESMINT 2021: COATING study “badly needed” to assess surface modification of...
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...
Neuros Medical completes enrolment in QUEST pivotal study of novel post-amputation...
Neuros Medical—a medical device company developing novel high-frequency nerve block technology for patients with intractable post-amputation pain—has announced the completion of enrolment in its pivotal QUEST...
Study indicates efficacy of hyperbaric oxygen therapy in reversing Alzheimer’s activators
A new study, published in the peer-reviewed medical journal Aging, marks the first time non-pharmaceutical clinical exploration has proved efficacious in reversing the main...
Novel teleproctoring platform successfully used for neuroendovascular fellowship training
A novel augmented reality (AR) platform (Proximie) has been successfully used to teleproctor a neuroendovascular fellow during complex interventional and diagnostic procedures. That is...
CRISP study indicates clinical benefit of non-paraesthesia-based approaches in burst SCS...
The CRISP (Comparison of paraesthesia mapping to anatomic midline-based burst programming strategies) study, published in Neuromodulation: Technology at the Neural Interface, has found that...
Sensome begins first-in-human trial of AI-powered stroke guidewire
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
NeuroNews issue 43 – US
Highlights:
A closer look at the latest clinical data regarding flow diversion technologies – including new insights on the Flow redirection endoluminal device (FRED;...
NeuroNews issue 43 – EU
Highlights:
A closer look at the latest clinical data regarding flow diversion technologies - including new insights on the Flow redirection endoluminal device (FRED;...
TCAR may be associated with favourable outcomes for treatment of restenotic...
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...
“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....
Neuromod Devices appoints Diarmuid Flavin as COO to boost expansion of...
Neuromod Devices has announced the appointment of Diarmuid Flavin as chief operating officer (COO). Flavin brings more than 25 years of global leadership experience...
Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA...
The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...
Flying intervention teams lead to higher EVT rates and reduced time...
Flying teams of interventionists directly to a primary stroke centre to perform endovascular therapy (EVT)—as opposed to waiting for the patient to be transferred...
NeuroOne Medical Technologies gains FDA 510(k) clearance for Evo SEEG electrode
NeuroOne Medical Technologies—a company focused on improving surgical care options and outcomes for patients with neurological disorders—has announced that it has received US Food...
NeuroNews’ top 10 most popular stories of August 2021
An exclusive interview covering a novel endovascular treatment option for communicating hydrocephalus (CH), the latest research involving deep brain stimulation (DBS) therapies, and data...
ESOC 2021: AI can calculate personalised risk of having another stroke
Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...
ESOC 2021: Non-traditional risk factors for heart attack and stroke rising...
Work stress, sleep disorders, and fatigue—which are regarded as non-traditional risk factors for heart attack and stroke—are rising more steeply among women than men,...
MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...
Presidio Medical publishes clinical and preclinical research on ULF neuromodulation therapy
Presidio Medical has announced that research involving its novel ultra-low frequency (ULF) neuromodulation therapy has been published in Science Translational Medicine. The publication, titled...
DTM SCS: A unique, tailored and highly effective therapy option for...
Michael Fishman (Wilmington, USA) discusses the benefits of Differential Target Multiplexed spinal cord stimulation (DTM SCS; Medtronic)—when compared to more conventional SCS therapy options—and...
Qure.ai lands second FDA clearance for AI-based brain scan technology
Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...
Postoperative admission of adult craniotomy patients to neuroscience ward reduces length...
Admitting adult craniotomy patients without significant comorbidities, who are expected to have a short length of stay, to the neuroscience ward has been associated...
Synchron announces US$10 million NIH grant for US COMMAND trial
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...
SyntheticMR and Siemens Healthineers extend collaboration with new license agreement
SyntheticMR has entered a general software license agreement for distribution with Siemens Healthineers. The agreement enables Siemens Healthineers to market, sell and distribute SyntheticMR's...
Neurosurgery with Surgical Theater’s VR and AR technologies set for first...
Rambam Healthcare Medical Center in Haifa, Israel is set to become the first medical centre in Israel to use virtual reality (VR) and augmented...
Q’Apel Medical launches Armadillo radial artery access platform
Q'Apel Medical announced today the launch of the Armadillo radial access system—the latest application of its SelectFlex technology and part of the SelectFlex family...
Behavioural interventions and more holistic approach signal “paradigm shift” in latest...
In May 2021, the American Heart Association (AHA)/American Stroke Association (ASA) updated one of its flagship guidelines—the secondary prevention of stroke guideline—for the first...
Temporary SCS could represent “new paradigm” in preventing atrial fibrillation
In a randomised pilot study, temporary spinal cord stimulation (SCS) has demonstrated efficacy in the suppression of postoperative atrial fibrillation (AF) following coronary artery...
Insightec announces Seoul National University Hospital is installing its Exablate Neuro...
Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro (Exablate 4000) platform—which uses focused ultrasound to ablate targets...
William Mack
William Mack is a professor of neurosurgery and vice-chair of academic affairs in the Department of Neurological Surgery at the University of Southern California...
Benefits of EVT for basilar artery occlusion “cannot be excluded” following...
A randomised controlled trial (RCT) involving 300 patients found that functional outcomes among basilar artery occlusion stroke patients “did not differ significantly” with endovascular...
Michael Chen becomes 26th president of SNIS
Michael Chen, a neurointerventionist at Rush University Medical Center in Chicago, USA, has been named the president of the Society of NeuroInterventional Surgery (SNIS)...
Fluid Biotech raises US$4.7 million in oversubscribed seed funding round
Fluid Biotech, a medical device start-up company based in Calgary, Canada, has announced the completion of an oversubscribed seed fundraising round totalling US$4.7 million—and...
Time is brain: Travelling stroke team enables faster treatment and better...
In a pilot programme in New York City, USA, a mobile interventional stroke team (MIST) travelled directly to patients to perform emergency stroke surgery...
Flow Neuroscience receives Series A funding to advance tDCS depression treatment
Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression,...
SpinTech earns FDA clearance for rapid, quantitative brain-imaging technology
The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (Strategically acquired gradient echo), the latest magnetic resonance imaging (MRI) technology...
Phenox highlights benefits of longer stentriever devices with new study results
Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...
Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...
FRED flow diverter safe and effective in treatment of “appropriately selected”...
The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...
Allegheny Health Network initiates clinical trial exploring use of DBS to...
A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US Food and Drug Administration (FDA) approval to begin the...
NeuroNews’ top 10 most popular stories of July 2021
A new technology to help surgeons reduce the risk of aneurysm regrowth, Philips’ most recent contributions to the field of stroke care, and evidence...
Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...
Synchron given green light to begin US study of endovascular brain-computer...
The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...
Gender disparity in comprehensive stroke centre routing highlighted at SNIS
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...
SNIS 2021: Remote stroke interventions raise several unique ethical challenges
At the Society of NeuroInterventional Surgery’s 18th annual meeting (SNIS; July 26–29 2021, Colorado Springs, USA and virtual), Jeffrey Saver, professor of Neurology at...
Balt completes enrolment in international study of low-profile Silk Vista flow...
Balt today announced that it has completed enrolment in its FIRST study—an observational, prospective, multicentre, international, single-arm study aiming to collect safety and efficacy...
Using new-generation CB-CT imaging tests may shorten time to surgery for...
Using a different type of computed tomography (CT) scan may reduce the time to essential surgery for patients with the deadliest kind of strokes—emergent...
Research shows new surgical technology may help reduce brain aneurysm regrowth
A new tool for treating brain aneurysms may protect artery blood flow during surgery and reduce the risk of aneurysm regrowth, according to a...
Black stroke patients undergo neuroendovascular surgery less often than white patients,...
Black patients with stroke are less likely than white patients to undergo a potentially lifesaving, minimally-invasive thrombectomy procedure to remove blood clots from arteries...
Neuro42 closes US$6.5 million Series A financing round
Neuro42, a US medical technology start-up focused on magnetic resonance imaging (MRI) and robotics, has announced the close of a US$6.5 million Series A...
Race among factors that predict how quickly patients get to stroke...
Race, in combination with other factors, predicted how quickly individuals with stroke got to care centres to receive necessary neuroendovascular surgery, including thrombectomy, according...
Cerenovus to unveil new data and showcase stroke care innovations at...
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...
Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...
Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients.
Best...
Omniscient Neurotechnology launches Quicktome brain-mapping platform following FDA clearance
Omniscient Neurotechnology has received US Food and Drug Administration (FDA) 510(k) clearance for Quicktome—a digital brain-mapping platform that allows neurosurgeons to visualise and understand...
Omniscient Neurotechnology raises AUD$40 million in Series B financing
Omniscient Neurotechnology, a Sydney-based brain-mapping technology company, has announced the completion of a AUD$40 million Series B financing round. The funding will allow Omniscient...
Nevro announces FDA approval of 10kHz high-frequency SCS therapy for painful...
Nevro has announced receipt of US Food and Drug Administration (FDA) approval for its Senza system for the treatment of chronic pain associated with...
NeuroNews issue 42 – US
Highlights:
Insight on the benefits of endovascular therapy (EVT) for basilar artery occlusion from the BASICS (Basilar artery international cooperation study) trial
Why the...
NeuroNews issue 42 – EU
Highlights:
Insight on the benefits of endovascular therapy (EVT) for basilar artery occlusion from the BASICS (Basilar artery international cooperation study) trial
Why the...
ASA highlights value of comprehensive, patient-centred primary care after stroke
In a new scientific statement entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA)—a division of the American Heart Association...
How stimulation is changing the future of mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...
Brainomix launches AI stroke software across Poland under POLKARD initiative
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...
BlueWind Medical enrols 100th patient in OASIS study of Renova iStim...
BlueWind Medical, a company making neuromodulation medical devices for the treatment of overactive bladder, has announced that the 100th patient has been enrolled in...
Kaneka announces sales expansion of brain aneurysm embolisation coils in the...
Kaneka Corporation has announced the signing of a sales alliance agreement with Asahi Intecc USA, through which—from August 2021 onwards—the company intends to further...
Repeated clot retrieval attempts linked to poorer functional outcome in acute...
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...
Philips enrols first patient in WE-TRUST stroke study to assess new...
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...
Robocath, Rennes University Hospital partner with Philips France to research stroke...
Robocath and Rennes University Hospital have announced they are launching a co-development research programme using robotics to improve treatments for stroke patients. With the...
Insightec announces approval of Exablate Neuro focused ultrasound platform in Singapore
Insightec has announced approval of its Exablate Neuro platform by the Health Sciences Authority (HSA) in Singapore. The Exablate Neuro (Exablate 4000) platform uses...
Men and women respond equally well to spinal cord and DRG...
In a study intended to explore gender differences in patients with failed back surgery syndrome (FBSS) or chronic visceral pain, men and women have...
Neuros Medical gains FDA Breakthrough Device designation for Altius nerve block...
Neuros Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the use of its novel, high-frequency nerve block...
NeuroNews’ top 10 most popular stories of June 2021
Fresh evidence on the differences between directional and omnidirectional deep brain stimulation (DBS), as well as regulatory approvals for a new reperfusion catheter and...
Viz.ai receives CE mark to bring AI-powered stroke care software to...
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
Mainstay Medical launches implantable restorative neurostimulation system in USA
Mainstay Medical has announced the limited US commercial launch of ReActiv8, its implantable restorative neurostimulation system to treat intractable chronic low back pain. The...
Flow diverter study with virtual participants “as effective as traditional clinical...
A study involving virtual participants—rather than real patients—was “as effective as traditional clinical trials” in evaluating the treatment of brain aneurysms using a flow...
New Stroke Association report to “shine a light” on stroke care’s...
The Stroke Association has announced the top areas of research that need to be prioritised to improve stroke care. The announcement of these priorities—which...
Epipole joins €1.1 million AI project to diagnose intracranial pressure
Video retinal imaging company Epipole has announced it has begun working on a €1.1 million collaborative project to develop a technology solution for the...
Penumbra receives FDA clearance for RED 62 reperfusion catheter
Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED 62 reperfusion catheter—the latest addition to the...
Stroke and heart condition patients want virtual healthcare to continue post...
After speaking with experts, reviewing current evidence, surveying people living with stroke or a heart condition, and funding a telephone poll of Canadians, the...
Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...
Neuromodulation device for treating MS-related gait deficit receives FDA authorisation
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...
Data from 1,000 aneurysms indicate Pipeline Embolization Device is safe and...
The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...
Medtronic announces FDA approval of recharge-free Vanta spinal cord stimulation implant
Medtronic has received US Food and Drug Administration (FDA) approval for Vanta—a high-performance, recharge-free implantable neurostimulator (INS) with a device life that can be...
Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...
Directional deep brain stimulation (DBS) has demonstrated benefits over omnidirectional DBS for the treatment of Parkinson’s disease in the largest prospective study in this...
Mitchell Elkind
Mitchell Elkind is a professor of Neurology and Epidemiology at Columbia University Irving Medical Center, and chief of the Division of Neurology Clinical Outcomes Research and Population...
FDA approves “first-of-its-kind” SenSight Directional Lead System for DBS therapy
Medtronic has announced US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System, which is used...
New algorithm could enable next-generation deep brain stimulation devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...
Vesalio secures Class A funding to bolster stroke treatment portfolio
Vesalio has successfully secured a Class A financing round. The company claims this funding will be utilised to support its ongoing US Investigational Device...
Higher incidence of severe stroke found in COVID-19 patients
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...
NeuroNews’ top 10 most popular stories of May 2021
New industry partnerships, the potential for energy savings in neuromodulation and the contentious topic of vertebral artery stenting were among the top stories that...
Avicenna.AI receives CE mark for AI tool to assess stroke severity
Medical imaging AI specialist Avicenna.AI has received CE mark certification for its CINA ASPECTS AI tool for stroke severity assessment. CINA ASPECTS automatically processes...
Clinical improvements seen following transvenous paraspinal vein embolisation for CSF hypotension
A case series to assess transvenous paraspinal vein embolisation of cerebrospinal fluid (CSF)-venous fistulas—a novel treatment approach for spontaneous intracranial hypotension (SIH)—has resulted in...
RapidAI unveils prehospital solution to optimise cross-team workflow and improve patient...
RapidAI has announced the launch of its Rapid prehospital workflow solution for stroke, which optimises coordination between emergency medical services (EMS) providers and hospital...
Livestreamed procedures close distance between clinicians and trainees during pandemic
Phil Taussky outlines a simple yet effective livestreaming platform that holds benefits for neurosurgeons during the ongoing COVID-19 crisis.
One of the challenges faced by...
HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter
HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...
Prevention based on first stroke cause can reduce risk of subsequent...
Identifying the cause of a stroke or transient ischaemic attack (TIA)—sometimes called a “mini-stroke”—can lead to specific prevention strategies to reduce the risk of...
Noninferiority of thrombectomy alone further demonstrated in acute ischaemic stroke treatment
The noninferiority of mechanical thrombectomy alone—compared to mechanical thrombectomy plus intravenous tissue plasminogen activator (IV-tPA)—for the treatment of acute ischaemic stroke has been demonstrated...
Study shows “major energy savings” can be achieved in spinal cord...
The results of the HALO (High and low frequency options) study, which are published online in the scientific journal Neuromodulation: Technology at the Neural...
Chordate Medical receives CE mark to treat chronic migraine with neuromodulation...
Chordate Medical has received a CE marking that permits its Kinetic Oscillation Stimulation (KOS) technology to be marketed, sold and used for the treatment...
Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to...
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...
First annual World Stroke Thrombectomy Day to be announced by SVIN...
The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2020+ Initiative (MT2020+) will announce the first annual World Stroke Thrombectomy Day at the...
Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment
US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...
rTMS found to be “well-accepted” for therapeutic use in psychiatric populations
Psychiatric populations perceive the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for mental health conditions to be beneficial, safe, and no more dangerous...
Perfuze announces CE mark and treats first patients with Millipede 088...
Neurovascular medical device company Perfuze has announced that the first five acute ischaemic stroke patients have been treated with its Millipede 088 clot aspiration...
Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...
CX 2021: Stenting should be reserved for the extracranial vertebral arteries...
Stenting is something that, for now at least, should be considered in the extracranial vertebral arteries only—and not the intracranial arteries—for symptomatic atherosclerotic stenosis,...
First US ischaemic stroke patients treated with Rapid Medical’s novel clot...
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...
IpsiHand System: New device for facilitating stroke rehabilitation gains FDA approval
The US Food and Drug Administration (FDA) has authorised marketing of a new device indicated for use in patients aged 18 and older undergoing...
Case report indicates 3D black blood vessel wall imaging can predict...
The early findings from a case report have highlighted the potential held by 3D black blood vessel wall post-contrast imaging to predict the outcomes...
Medtronic and Surgical Theater to provide first real-time AR platform for...
Medtronic will partner with American health technology firm Surgical Theater to provide the first augmented reality (AR) platform for use in real time during...
UK charity funds “world-first” study into long-term COVID-19 impact on stroke
Leading UK charity the Stroke Association is funding what it claims will be the world’s first study to determine the long-term impact of COVID-19...
First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic...
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...
Thrombolysis versus thrombectomy: Honours even between basilar occlusion treatments in CX...
Thrombolysis is considered as effective as mechanical thrombectomy for the treatment of basilar artery occlusion (BAO)—despite existing evidence on both intervention options being limited....
Medtronic gains FDA approval to trial implantable tibial neuromodulation device
Medtronic has announced approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate its...
PreSize Neurovascular software launched at first UK NHS hospital
Doctors at St George’s Hospital in London, UK are set to become the first within the UK National Health Service (NHS) to begin using Oxford Heartbeat’s...
More trained interventionalists needed to treat stroke “on the spot”
Nick Hopkins (Buffalo, USA) talks to BLearning Neuro at VEITH Symposium 2018 (13–17 November, New York, USA) about the DAWN trial, which showed that, in...
Stryker gains US FDA premarket approval for Neuroform Atlas stent system
Stryker has announced the premarket approval (PMA) of the Neuroform Atlas stent system by the US Food and Drug Administration (FDA).
Neuroform Atlas—according to the...
Stryker launches next-generation flow diverter for treatment of brain aneurysms
Stryker has announced the availability of the Surpass Evolve flow diverter following CE-mark approval in March. Surpass Evolve is Stryker’s latest entrant into the...
